KR102641072B1 - Lip balm composition and lip balm prepared including the same - Google Patents
Lip balm composition and lip balm prepared including the same Download PDFInfo
- Publication number
- KR102641072B1 KR102641072B1 KR1020230074765A KR20230074765A KR102641072B1 KR 102641072 B1 KR102641072 B1 KR 102641072B1 KR 1020230074765 A KR1020230074765 A KR 1020230074765A KR 20230074765 A KR20230074765 A KR 20230074765A KR 102641072 B1 KR102641072 B1 KR 102641072B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- parts
- prepared
- lip balm
- solution
- Prior art date
Links
- 239000007934 lip balm Substances 0.000 title claims abstract description 62
- 239000000203 mixture Substances 0.000 title claims abstract description 43
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000010460 hemp oil Substances 0.000 claims abstract description 24
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 claims abstract description 19
- 241001135917 Vitellaria paradoxa Species 0.000 claims abstract description 19
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims abstract description 19
- 229940057910 shea butter Drugs 0.000 claims abstract description 16
- 235000011187 glycerol Nutrition 0.000 claims abstract description 13
- 235000019271 petrolatum Nutrition 0.000 claims abstract description 13
- 239000004264 Petrolatum Substances 0.000 claims abstract description 10
- 229940066842 petrolatum Drugs 0.000 claims abstract description 10
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 66
- 239000011707 mineral Substances 0.000 claims description 66
- 239000000843 powder Substances 0.000 claims description 29
- 239000000243 solution Substances 0.000 claims description 29
- 244000025254 Cannabis sativa Species 0.000 claims description 28
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 claims description 27
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 claims description 27
- 235000009120 camo Nutrition 0.000 claims description 27
- 235000005607 chanvre indien Nutrition 0.000 claims description 27
- 239000011487 hemp Substances 0.000 claims description 27
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 238000002156 mixing Methods 0.000 claims description 19
- 239000008213 purified water Substances 0.000 claims description 19
- 239000000284 extract Substances 0.000 claims description 17
- 108090000790 Enzymes Proteins 0.000 claims description 15
- 102000004190 Enzymes Human genes 0.000 claims description 15
- 238000005406 washing Methods 0.000 claims description 15
- 238000010438 heat treatment Methods 0.000 claims description 13
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 12
- OSVXSBDYLRYLIG-UHFFFAOYSA-N dioxidochlorine(.) Chemical compound O=Cl=O OSVXSBDYLRYLIG-UHFFFAOYSA-N 0.000 claims description 12
- 238000006460 hydrolysis reaction Methods 0.000 claims description 12
- 239000003921 oil Substances 0.000 claims description 11
- 235000019198 oils Nutrition 0.000 claims description 11
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 10
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 230000007062 hydrolysis Effects 0.000 claims description 9
- 239000000047 product Substances 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- 241000894006 Bacteria Species 0.000 claims description 8
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 claims description 8
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 8
- 238000000855 fermentation Methods 0.000 claims description 7
- 230000004151 fermentation Effects 0.000 claims description 7
- 239000003205 fragrance Substances 0.000 claims description 7
- 230000001954 sterilising effect Effects 0.000 claims description 7
- 239000006228 supernatant Substances 0.000 claims description 7
- 239000004155 Chlorine dioxide Substances 0.000 claims description 6
- 235000010323 ascorbic acid Nutrition 0.000 claims description 6
- 239000011668 ascorbic acid Substances 0.000 claims description 6
- 229960005070 ascorbic acid Drugs 0.000 claims description 6
- 235000019398 chlorine dioxide Nutrition 0.000 claims description 6
- 239000010450 olivine Substances 0.000 claims description 6
- 229910052609 olivine Inorganic materials 0.000 claims description 6
- -1 polyethylene Polymers 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 claims description 5
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 claims description 5
- WKBPZYKAUNRMKP-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)pentyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(CCC)CN1C=NC=N1 WKBPZYKAUNRMKP-UHFFFAOYSA-N 0.000 claims description 5
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 claims description 5
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 5
- 239000004698 Polyethylene Substances 0.000 claims description 5
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 claims description 5
- 235000013871 bee wax Nutrition 0.000 claims description 5
- 239000012166 beeswax Substances 0.000 claims description 5
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 claims description 5
- 238000000227 grinding Methods 0.000 claims description 5
- 229940119170 jojoba wax Drugs 0.000 claims description 5
- 229940087305 limonene Drugs 0.000 claims description 5
- 235000001510 limonene Nutrition 0.000 claims description 5
- 239000004200 microcrystalline wax Substances 0.000 claims description 5
- 235000019808 microcrystalline wax Nutrition 0.000 claims description 5
- 239000011259 mixed solution Substances 0.000 claims description 5
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 claims description 5
- 239000004006 olive oil Substances 0.000 claims description 5
- 235000008390 olive oil Nutrition 0.000 claims description 5
- 229920000573 polyethylene Polymers 0.000 claims description 5
- 229960005078 sorbitan sesquioleate Drugs 0.000 claims description 5
- 239000011031 topaz Substances 0.000 claims description 5
- 229910052853 topaz Inorganic materials 0.000 claims description 5
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims description 4
- 239000001509 sodium citrate Substances 0.000 claims description 4
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 239000001384 succinic acid Substances 0.000 claims description 4
- 229940099259 vaseline Drugs 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 239000010419 fine particle Substances 0.000 claims description 3
- 229940107702 grapefruit seed extract Drugs 0.000 claims description 3
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 claims description 3
- 229910052900 illite Inorganic materials 0.000 claims description 3
- VGIBGUSAECPPNB-UHFFFAOYSA-L nonaaluminum;magnesium;tripotassium;1,3-dioxido-2,4,5-trioxa-1,3-disilabicyclo[1.1.1]pentane;iron(2+);oxygen(2-);fluoride;hydroxide Chemical compound [OH-].[O-2].[O-2].[O-2].[O-2].[O-2].[F-].[Mg+2].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[K+].[K+].[K+].[Fe+2].O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2 VGIBGUSAECPPNB-UHFFFAOYSA-L 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 238000000354 decomposition reaction Methods 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 abstract description 8
- 235000010755 mineral Nutrition 0.000 description 54
- 210000003491 skin Anatomy 0.000 description 51
- 230000000052 comparative effect Effects 0.000 description 20
- 230000000694 effects Effects 0.000 description 17
- 230000003020 moisturizing effect Effects 0.000 description 15
- 229940088598 enzyme Drugs 0.000 description 14
- 235000011007 phosphoric acid Nutrition 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 11
- 239000000523 sample Substances 0.000 description 11
- 230000003078 antioxidant effect Effects 0.000 description 10
- 239000004615 ingredient Substances 0.000 description 9
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- 208000003251 Pruritus Diseases 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 8
- 244000062730 Melissa officinalis Species 0.000 description 7
- 235000010654 Melissa officinalis Nutrition 0.000 description 7
- 239000000865 liniment Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 230000002292 Radical scavenging effect Effects 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- 230000007803 itching Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 6
- 240000000560 Citrus x paradisi Species 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000007794 irritation Effects 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 230000003301 hydrolyzing effect Effects 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- 229910052749 magnesium Inorganic materials 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 239000011574 phosphorus Substances 0.000 description 4
- 229910052698 phosphorus Inorganic materials 0.000 description 4
- 238000010298 pulverizing process Methods 0.000 description 4
- 230000009759 skin aging Effects 0.000 description 4
- 210000004927 skin cell Anatomy 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- UNZOESWLBMZBEY-YHZPTAEISA-N bis(16-methylheptadecyl) (z)-but-2-enedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)\C=C/C(=O)OCCCCCCCCCCCCCCCC(C)C UNZOESWLBMZBEY-YHZPTAEISA-N 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 238000001354 calcination Methods 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 230000001877 deodorizing effect Effects 0.000 description 3
- 239000000645 desinfectant Substances 0.000 description 3
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 230000000243 photosynthetic effect Effects 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- 241000228215 Aspergillus aculeatus Species 0.000 description 2
- 206010003645 Atopy Diseases 0.000 description 2
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical compound CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 108010059820 Polygalacturonase Proteins 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- CYQFCXCEBYINGO-UHFFFAOYSA-N THC Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 239000004927 clay Substances 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 229960004242 dronabinol Drugs 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 235000004626 essential fatty acids Nutrition 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 108010093305 exopolygalacturonase Proteins 0.000 description 2
- 229940059442 hemicellulase Drugs 0.000 description 2
- 108010002430 hemicellulase Proteins 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 2
- 230000037311 normal skin Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 229940005657 pyrophosphoric acid Drugs 0.000 description 2
- 230000000191 radiation effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000008591 skin barrier function Effects 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 101710130006 Beta-glucanase Proteins 0.000 description 1
- 241000218235 Cannabaceae Species 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000218691 Cupressaceae Species 0.000 description 1
- SBJKKFFYIZUCET-JLAZNSOCSA-N Dehydro-L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-JLAZNSOCSA-N 0.000 description 1
- SBJKKFFYIZUCET-UHFFFAOYSA-N Dehydroascorbic acid Natural products OCC(O)C1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-UHFFFAOYSA-N 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 1
- 241000792859 Enema Species 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 229910019093 NaOCl Inorganic materials 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 241000191023 Rhodobacter capsulatus Species 0.000 description 1
- 241000191043 Rhodobacter sphaeroides Species 0.000 description 1
- 241000190984 Rhodospirillum rubrum Species 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010040954 Skin wrinkling Diseases 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 208000035868 Vascular inflammations Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 238000000498 ball milling Methods 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 229940093797 bioflavonoids Drugs 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000012928 buffer substance Substances 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000004098 cellular respiration Effects 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 229940044176 ceramide 3 Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 235000020960 dehydroascorbic acid Nutrition 0.000 description 1
- 239000011615 dehydroascorbic acid Substances 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000007920 enema Substances 0.000 description 1
- 229940095399 enema Drugs 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000003646 hair health Effects 0.000 description 1
- 230000003400 hallucinatory effect Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 230000036640 muscle relaxation Effects 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 1
- 229940052490 naringin Drugs 0.000 description 1
- 229930019673 naringin Natural products 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000013503 personal care ingredient Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000013077 scoring method Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- UKLNMMHNWFDKNT-UHFFFAOYSA-M sodium chlorite Chemical compound [Na+].[O-]Cl=O UKLNMMHNWFDKNT-UHFFFAOYSA-M 0.000 description 1
- 229960002218 sodium chlorite Drugs 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000003206 sterilizing agent Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 150000003464 sulfur compounds Chemical class 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000001040 synthetic pigment Substances 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- OBSZRRSYVTXPNB-UHFFFAOYSA-N tetraphosphorus Chemical compound P12P3P1P32 OBSZRRSYVTXPNB-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000000515 tooth Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 150000007521 triprotic acids Chemical class 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/001—Preparations for care of the lips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 립밤 조성물 및 이를 포함하여 제조된 립밤에 관한 것이다.
본 발명의 기술적 사상의 일 실시예에 따른 립밤 조성물은, 시어버터(Shea butter), 헴프시드 오일(Hempseed oil), 세라마이드 엔피(Ceramide NP), 글리세린(Glycerin) 및 바셀린(petrolatum)을 유효성분으로 포함한다.
상기한 구성에 의해 본 발명의 기술적 사상의 다양한 실시예에 의한 립밤 조성물을 포함하는 립밤은, 피부트러블 없이 연약한 입술을 건강하게 유지할 수 있고 보습 뿐만 아니라 입술의 아름다운 케어가 가능하다.The present invention relates to a lip balm composition and a lip balm manufactured including the same.
The lip balm composition according to an embodiment of the technical idea of the present invention contains shea butter, hempseed oil, Ceramide NP, glycerin, and petrolatum as active ingredients. Includes.
With the above-described structure, a lip balm containing a lip balm composition according to various embodiments of the technical idea of the present invention can keep delicate lips healthy without skin trouble and can provide not only moisturization but also beautiful care for the lips.
Description
본 발명은 립밤 조성물 및 이를 포함하여 제조된 립밤에 관한 것으로서, 더욱 상세하게는 피부트러블 없이 연약한 입술을 건강하게 유지할 수 있고 보습 뿐만 아니라 입술의 아름다운 케어가 가능한 립밤 조성물 및 이를 포함하여 제조된 립밤에 관한 것이다.The present invention relates to a lip balm composition and a lip balm manufactured including the same. More specifically, it relates to a lip balm composition that can keep delicate lips healthy without skin trouble and provides not only moisturization but also beautiful care for the lips, and a lip balm manufactured including the same. It's about.
일반적으로, 입술은 끊임없이 수축 및 팽창하여 신체 부위 중 가장 움직임이 많은 부위일 뿐만 아니라, 항상 외부에 노출되어 환경적인 요인에 의해 쉽게 영향을 받는 신체 부위로, 일반적인 피부와는 그 구조가 달라서 피지막이 없으며 각질층이 매우 얇게 형성되어 있어, 외부의 자극 요인에 대한 자체적인 방어 능력이 매우 약해 외인성 노화에 유독 취약한 부위라 할 수 있다.In general, the lips are not only the most mobile part of the body as they constantly contract and expand, but they are also a body part that is always exposed to the outside and easily affected by environmental factors. Their structure is different from normal skin, so they form a sebum film. Since the stratum corneum is formed very thinly, its own defense ability against external irritants is very weak, making it a particularly vulnerable area to extrinsic aging.
또한, 입술은 다른 피부와는 달리 얇은 각질층으로 구성되어 일반 피부에 비해, 외용제에 대해 더욱 예민하고 민감하게 반응하기 때문에 합성 오일과, 왁스, 소량의 합성색소 형태의 유성성분으로 이루어지는 립밤을 사용하는 경우, 간지러움, 따가움 또는 통증이 쉽게 유발될 수 있어, 천연 성분들을 활용하여 립밤과 같은 입술용 화장품의 개발이 지속적으로 연구되고 있다.In addition, unlike other skin, the lips are composed of a thin keratin layer and are more sensitive and sensitive to external agents than regular skin, so it is recommended to use a lip balm made of oil-based ingredients in the form of synthetic oil, wax, and a small amount of synthetic pigment. In this case, itching, stinging, or pain can easily be caused, so research is ongoing on the development of lip cosmetics such as lip balm using natural ingredients.
일반적으로 피부 노화, 지속적인 스트레스의 누적 또는 오염된 환경에 의해 건조한 피부가 증가하는 경향을 보인다. 이러한 피부 건조화의 원인으로서 특히 황사, 먼지, 공해 등의 양이온성 물질들이 피부에 부착되면서 각종 피부 자극, 알러지 등을 유발하거나 정상적인 피부 장벽의 회복 기능을 저해하여 피부의 건조화를 가속화시키고 있다. 이를 예방하고 완화시키기 위해서는 보습제를 충분히 바름으로써 피부의 보습력을 유지시키는 것이 중요하다.In general, dry skin tends to increase due to skin aging, continuous accumulation of stress, or a polluted environment. As a cause of this skin drying, in particular, cationic substances such as yellow dust, dust, and pollution adhere to the skin, causing various skin irritations and allergies, or impeding the normal skin barrier recovery function, thereby accelerating drying of the skin. To prevent and alleviate this, it is important to maintain the skin's moisturizing power by applying sufficient moisturizer.
한편, 립밤은 체내 유입 가능성이 높아 립밤에 함유되어 있는 바셀린이나 라놀린 성분은 다량으로 많이 사용할 경우 인체에 유해할 수 있다는 보고가 있어 원료와 성분의 안전성이 요구되고 있다. 특히, 입술은 다른 피부와는 달리 얇은 각질층으로 구성되어 일반 피부에 비해, 외용제에 대해 더욱 예민하고 민감하게 반응하기 때문에 입술용 화장료 조성물에 대해 간지러움, 따가움 또는 통증이 쉽게 유발될 수 있다.Meanwhile, lip balm has a high possibility of entering the body, and it has been reported that the petroleum jelly or lanolin contained in lip balm can be harmful to the human body if used in large quantities, so the safety of raw materials and ingredients is required. In particular, unlike other skin, the lips are composed of a thin keratin layer and are more sensitive and sensitive to external agents than regular skin, so itching, stinging, or pain can easily be caused by cosmetic compositions for the lips.
뿐만 아니라, 이러한 립밤은 경도를 향상시키고 보습 효과를 주기 위해 왁스류를 주로 포함하고 있으나, 이러한 왁스류의 경우 온도 변화에 민감하여 제형이 불안정하다는 단점을 갖는다. 특히, 여름철의 경우 쉬이 용해되어 사용이 불편하거나, 쉽게 뭉그러지며 묻어나는 양이 많아져 입술에 균일하게 도포되지 않고 입술 라인을 따라 번짐 현상이 나타날 수 있어 사용감이 하락하는 원인이 된다.In addition, these lip balms mainly contain waxes to improve hardness and provide a moisturizing effect, but these waxes have the disadvantage of being sensitive to temperature changes and making the formulation unstable. In particular, in the summer, it dissolves easily, making it inconvenient to use, or it crumbles easily and the amount that sticks out increases, so it is not applied evenly to the lips and may spread along the lip line, which reduces the feeling of use.
이에 따라, 입술의 보습력을 향상시키는 효과가 우수하면서도, 립밤의 반복적인 사용에 따라 발생하는 각질, 가려움 등을 동반한 피부트러블의 발생을 방지하고, 세포 독성이 거의 없어 인체에 안전한 립밤 조성물에 대한 개발의 필요성이 증대되고 있는 실정이다.Accordingly, a lip balm composition that has an excellent effect of improving the moisturizing power of the lips, prevents skin troubles such as dead skin cells and itching that occurs due to repeated use of lip balm, and is safe for the human body as it has little cytotoxicity. The need for development is increasing.
본 발명이 해결하고자 하는 과제는, 피부트러블 없이 연약한 입술을 건강하게 유지할 수 있고 보습 뿐만 아니라 입술의 아름다운 케어가 가능한 립밤 조성물 및 이를 포함하여 제조된 립밤을 제공하는데 있다.The problem to be solved by the present invention is to provide a lip balm composition that can keep delicate lips healthy without causing skin trouble and that not only moisturizes but also provides beautiful care for the lips, and a lip balm manufactured including the same.
또한, 본 발명이 해결하고자 하는 과제는, 립밤의 반복적인 사용에 따라 발생하는 각질, 가려움 등을 동반한 피부트러블의 발생을 방지하고, 입술에 보호막을 형성하여 수분이 증발되는 것을 방지함으로써 입술 피부의 보습력 향상시키며, 입술을 항상 촉촉한 상태로 유지시킬 수 있는 립밤 조성물 및 이를 포함하여 제조된 립밤을 제공하는데 있다.In addition, the problem that the present invention aims to solve is to prevent the occurrence of skin troubles such as dead skin cells and itching that occur due to repeated use of lip balm, and to form a protective film on the lips to prevent moisture from evaporating, thus protecting the lip skin. The aim is to provide a lip balm composition that improves moisturizing ability and keeps lips moist at all times, and a lip balm manufactured including the same.
본 발명이 해결하고자 하는 다양한 과제들은 이상에서 언급한 과제들에 제한되지 않으며, 언급되지 않은 또 다른 과제들은 아래의 기재로부터 당업자에게 명확하게 이해될 수 있을 것이다.The various problems to be solved by the present invention are not limited to the problems mentioned above, and other problems not mentioned will be clearly understood by those skilled in the art from the description below.
본 발명의 기술적 사상의 일 실시예에서는 립밤 조성물을 개시한다.In one embodiment of the technical idea of the present invention, a lip balm composition is disclosed.
상기 립밤 조성물은, 시어버터(Shea butter), 헴프시드 오일(Hempseed oil), 세라마이드 엔피(Ceramide NP), 글리세린(Glycerin) 및 바셀린(petrolatum)을 유효성분으로 포함한다.The lip balm composition includes shea butter, hempseed oil, Ceramide NP, glycerin, and petrolatum as active ingredients.
상기 시어버터(Shea butter) 0.5 내지 1.5g, 헴프시드 오일(Hempseed oil) 0.3 내지 0.7㎖, 세라마이드 엔피(Ceramide NP) 0.3 내지 0.7g, 글리세린(Glycerin) 0.3 내지 0.7㎖ 및 바셀린(petrolatum) 0.3 내지 0.7g의 비율로 포함될 수 있다.0.5 to 1.5 g of shea butter, 0.3 to 0.7 ml of hempseed oil, 0.3 to 0.7 g of Ceramide NP, 0.3 to 0.7 ml of glycerin, and 0.3 to 0.3 to 0.7 ml of petrolatum. It may be included at a rate of 0.7g.
또한, 본 발명의 기술적 사상의 다른 실시예에서는 상기한 조성물을 포함하여 제조된 립밤을 개시한다.In addition, in another embodiment of the technical idea of the present invention, a lip balm manufactured including the composition described above is disclosed.
기타 실시예들의 구체적인 사항들은 상세한 설명에 포함되어 있다.Specific details of other embodiments are included in the detailed description.
본 발명의 기술적 사상의 다양한 실시예에 의한 립밤 조성물을 포함하는 립밤은, 피부트러블 없이 연약한 입술을 건강하게 유지할 수 있고 보습 뿐만 아니라 입술의 아름다운 케어가 가능하다.Lip balm containing a lip balm composition according to various embodiments of the technical idea of the present invention can keep delicate lips healthy without skin trouble and can provide not only moisturization but also beautiful care for the lips.
또한, 본 발명의 기술적 사상의 다양한 실시예에 의한 립밤 조성물을 포함하는 립밤은, 립밤의 반복적인 사용에 따라 발생하는 각질, 가려움 등을 동반한 피부트러블의 발생을 방지하고, 입술에 보호막을 형성하여 수분이 증발되는 것을 방지함으로써 입술 피부의 보습력 향상시키며, 입술을 항상 촉촉한 상태로 유지시킬 수 있다.In addition, the lip balm containing the lip balm composition according to various embodiments of the technical idea of the present invention prevents the occurrence of skin troubles such as dead skin cells and itching that occur due to repeated use of the lip balm, and forms a protective film on the lips. By preventing moisture from evaporating, it improves the moisturizing power of the lip skin and keeps the lips moist at all times.
본 발명의 기술적 사상의 다양한 실시예는, 구체적으로 언급되지 않은 다양한 효과를 제공할 수 있다는 것이 충분히 이해될 수 있을 것이다.It will be fully understood that various embodiments of the technical idea of the present invention can provide various effects that are not specifically mentioned.
도 1은 본 발명의 기술적 사상의 일 실시예에 따른 립밤 조성물을 포함하여 제조된 립밥의 일 예를 보여주는 사진이다.Figure 1 is a photograph showing an example of lip balm manufactured including a lip balm composition according to an embodiment of the technical idea of the present invention.
본 발명의 이점 및 특징, 그리고 그것들을 달성하는 방법은 상세하게 후술되어 있는 실시예를 참조하면 명확해질 것이다. 그러나 본 발명은 여기서 설명되는 실시예들에 한정되지 않고 다른 형태로 구체화될 수도 있다. 오히려, 여기서 소개되는 실시예들은 개시된 내용이 철저하고 완전해질 수 있도록 그리고 당업자에게 본 발명의 사상이 충분히 전달될 수 있도록 하기 위해 제공되는 것이다.The advantages and features of the present invention, and methods for achieving them, will become clear with reference to the embodiments described in detail below. However, the present invention is not limited to the embodiments described herein and may be embodied in other forms. Rather, the embodiments introduced herein are provided so that the disclosure will be thorough and complete and so that the spirit of the invention can be sufficiently conveyed to those skilled in the art.
본 출원에서 사용한 용어는 단지 특정한 실시예를 설명하기 위해 사용된 것으로, 본 발명을 한정하려는 의도가 아니다. 단수의 표현은 문맥상 명백하게 다르게 뜻하지 않는 한, 복수의 표현을 포함한다.The terms used in this application are only used to describe specific embodiments and are not intended to limit the invention. Singular expressions include plural expressions unless the context clearly dictates otherwise.
다르게 정의되지 않는 한, 기술적이거나 과학적인 용어를 포함해서 여기서 사용되는 모든 용어들은 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자에 의해 일반적으로 이해되는 것과 동일한 의미가 있다. 일반적으로 사용되는 사전에 정의되어 있는 것과 같은 용어들은 관련 기술의 문맥상 가지는 의미와 일치하는 의미가 있는 것으로 해석되어야 하며, 본 출원에서 명백하게 정의하지 않는 한, 이상적이거나 과도하게 형식적인 의미로 해석되지 않는다.Unless otherwise defined, all terms used herein, including technical or scientific terms, have the same meaning as generally understood by a person of ordinary skill in the technical field to which the present invention pertains. Terms defined in commonly used dictionaries should be interpreted as having a meaning consistent with the meaning in the context of the related technology, and should not be interpreted as having an ideal or excessively formal meaning unless explicitly defined in the present application. No.
이하, 첨부된 도면을 참조하여 본 발명의 기술적 사상의 일 실시예에 따른 립밤 조성물에 대하여 바람직한 실시예를 들어 상세하게 설명한다.Hereinafter, a lip balm composition according to an embodiment of the technical idea of the present invention will be described in detail with preferred embodiments with reference to the attached drawings.
도 1은 본 발명의 기술적 사상의 일 실시예에 따른 립밤 조성물을 포함하여 제조된 립밥의 일 예를 보여주는 사진이다.Figure 1 is a photograph showing an example of lip balm manufactured including a lip balm composition according to an embodiment of the technical idea of the present invention.
도 1을 참조하면, 본 발명의 기술적 사상의 일 실시예에 따른 립밤 조성물은 시어버터(Shea butter), 헴프시드 오일(Hempseed oil), 세라마이드 엔피(Ceramide NP), 글리세린(Glycerin) 및 바셀린(petrolatum)을 유효성분으로 포함한다.Referring to Figure 1, the lip balm composition according to an embodiment of the technical idea of the present invention includes shea butter, hempseed oil, Ceramide NP, glycerin, and petrolatum. ) is included as an active ingredient.
또한, 본 발명의 기술적 사상의 일 실시예에 따른 립밤 조성물은 시어버터(Shea butter) 0.5 내지 1.5g, 헴프시드 오일(Hempseed oil) 0.3 내지 0.7㎖, 세라마이드 엔피(Ceramide NP) 0.3 내지 0.7g, 글리세린(Glycerin) 0.3 내지 0.7㎖ 및 바셀린(petrolatum) 0.3 내지 0.7g의 비율로 포함될 수 있다.In addition, the lip balm composition according to an embodiment of the technical idea of the present invention includes 0.5 to 1.5 g of shea butter, 0.3 to 0.7 ml of hempseed oil, 0.3 to 0.7 g of Ceramide NP, It may be included in a ratio of 0.3 to 0.7 ml of glycerin and 0.3 to 0.7 g of petrolatum.
또한, 상기 시어버터(Shea butter)는 고체 상태에서 열을 가하여 용융시킴으로써 제조된 액체 상태의 시어버터가 사용될 수 있다.In addition, the shea butter may be a liquid shea butter prepared by melting the solid state by applying heat.
또한, 상기 세라마이드 엔피(Ceramide NP)는 평균 입자 크기가 0.05 내지 2.5㎛이고, 상기 세라마이드 엔피(Ceramide NP)는 0.5% 세라마이드 엔피(Ceramide NP) 수용액이 사용될 수 있다.In addition, the Ceramide NP has an average particle size of 0.05 to 2.5㎛, and a 0.5% aqueous solution of Ceramide NP may be used.
상기 시어버터(Shea butter)는 시어나무열매(시어너트)의 속 씨앗으로부터 추출된 강력한 항염효과를 지닌 식물성 오일로 학명은 부티로스퍼멈파키(Butyrospermum parkii)이다. 시어버터는 약간 노란색을 띠고 있는 지방산 추출물로 구성물의 25~30%가 항산화(phenolics) 성분으로 구성되어 있다. 천연비타민(A, D, E, F), 항염, 면역조절의 파이토스테롤성분, 폴리페놀, 토코페롤 등 유익한 생화학적 활성 성분이 풍부하며, 항산화, 항염 기능이 뛰어나 특히 아토피성 염증에 진정 효과가 있는 것으로 알려져 있다.The shea butter is a vegetable oil with a strong anti-inflammatory effect extracted from the seeds of the shea tree fruit (shea nut) and its scientific name is Butyrospermum parkii. Shea butter is a slightly yellow fatty acid extract, and 25-30% of it is made up of antioxidants (phenolics). It is rich in beneficial biochemical active ingredients such as natural vitamins (A, D, E, F), anti-inflammatory and immunomodulating phytosterol components, polyphenols, and tocopherol, and has excellent antioxidant and anti-inflammatory functions, especially having a soothing effect on atopic inflammation. It is known that
또한, 상기 시어버터는 비타민 A, E, F 등이 풍부하여 피부 노화방지에 효과적이고, 수분의 보호막 형성에 뛰어난 작용을 하고, 거칠고 건조한 피부를 촉촉하게 하는 보습이 뛰어나며, 이외에도 모발 건강, 항염, 항균 효과가 있다고 알려져 있다.In addition, the shea butter is rich in vitamins A, E, F, etc., so it is effective in preventing skin aging, has an excellent effect on forming a moisture barrier, and is excellent at moisturizing rough and dry skin. In addition, it has hair health, anti-inflammatory, and other benefits. It is known to have antibacterial effects.
상기 헴프시드 오일은 헴프시드(Hemp Seed)로부터 제조될 수 있는데, 상기 햄프(Cannabis sativa L)는, 삼, 마 또는 대마로 불리는 삼과의 한해살이 풀의 일종이다. 본 발명에서 상기 헴프시드는 상기 헴프의 씨앗을 의미하는데, 상기 헴프시드는 타원형에 길이는 약 5㎜ 정도로 겉껍질은 갈색이고, 겉껍질을 제거하면 크림색 또는 초록빛이 도는 크림색을 띈다. 겉껍질을 벗긴 헴프시드는 식품, 화장품으로 활용되며, 국내에서는 환각성분인 테트라히드로카나비놀(Tetrahydrocannabinol, THC) 검사를 거쳐서 안정성이 확인된 후에 유통된다.The hemp seed oil can be manufactured from hemp seed, which is a type of annual grass of the hemp family called hemp, hemp, or hemp. In the present invention, the hemp seed refers to the seed of the hemp. The hemp seed is oval-shaped and about 5 mm long, has a brown outer skin, and takes on a cream-colored or greenish-cream color when the outer skin is removed. Hemp seeds that have been peeled are used as food and cosmetics, and in Korea, they are distributed after their safety is confirmed through testing for tetrahydrocannabinol (THC), a hallucinogenic ingredient.
상기 헴프시드 오일은 필수 지방산, 비타민 A, D, E, 미네랄, 오메가 3, 6을 포함하고 있는 것으로 알려져 있는데, 생선에서 추출한 오일을 제외하고 식물의 씨앗으로부터 오메가 3, 오메가 6을 함유하는 유일한 식물성 오일로 알려져 있다. 다른 식물성 오일 보다 많은 필수 지방산을 함유하는 것으로 오메가 6, 오메가 3의 비율이 3:1을 가지며, 천연 항산화제 비타민 E와 콜레스테롤의 흡수를 막는 스테롤이 함유되어 있다.The hemp seed oil is known to contain essential fatty acids, vitamins A, D, E, minerals, and omega 3 and 6. Excluding oil extracted from fish, hemp seed oil is the only plant that contains omega 3 and omega 6 from plant seeds. Known as oil. It contains more essential fatty acids than other vegetable oils and has a 3:1 ratio of omega 6 to omega 3, and contains natural antioxidant vitamin E and sterols that block the absorption of cholesterol.
또한, 헴프시드 오일은 알파리놀레산(Alpha-Linolenic Acid; ALA)과 감마리놀레산이 풍부하여 사람의 피부 보습 및 피부를 부드럽게 하는 기능뿐만 아니라, 인, 칼륨, 마그네슘, 황, 칼슘과 철, 아연 등의 미네랄도 풍부하게 함유하고 있으며, 혈액순환 및 근육완화 작용을 하여 근육통 및 신경통에 효과적인 것으로 알려져 있다.In addition, hemp seed oil is rich in alpha-linolenic acid (ALA) and gamma-linolenic acid, which not only moisturizes and softens human skin, but also contains phosphorus, potassium, magnesium, sulfur, calcium, iron, and zinc. It is also rich in minerals and is known to be effective in treating muscle pain and neuralgia by improving blood circulation and muscle relaxation.
이러한 헴프시드 오일을 복용하면 인체의 콜레스테롤 농도를 낮추고, 혈관염증을 치료하며, 피를 맑게 하여 고혈압과 심장질환 및 발작을 감소시키는 기능으로도 작용한다. 특히, 피부에 바르게 되면 피부 보습을 유지하고, 피부 노화방지 및 피부재생 효과가 탁월하며, 아토피 피부에 사용하면 가려움증을 어느 정도 해소할 수 있는 작용을 한다.Taking hemp seed oil lowers the body's cholesterol level, treats vascular inflammation, and purifies the blood to reduce high blood pressure, heart disease, and stroke. In particular, when applied to the skin, it maintains skin moisture, has excellent skin aging prevention and skin regeneration effects, and when used on atopic skin, it relieves itching to some extent.
상기 헴프시드 오일은 시중에 판매되고 있는 공지의 헴프시드 오일을 구입하여 사용하거나, 또는, 하기의 방법으로 제조된 헴프시드 오일이 사용될 수도 있다.The hemp seed oil may be used by purchasing a known commercially available hemp seed oil, or hemp seed oil prepared by the following method may be used.
먼저, 상기 헴프시드 오일을 제조하기 위하여, 헴프시드를 준비한 후 세척할 수 있다.First, to prepare the hemp seed oil, hemp seeds can be prepared and then washed.
다음으로, 상기 세척된 헴프시드를 분쇄하여 분말화함으로써 헴프시드 분말을 제조할 수 있다.Next, hemp seed powder can be produced by pulverizing the washed hemp seeds and powdering them.
상기 세척된 헴프시드의 분쇄는 공지된 분쇄기를 이용하여 수행할 수 있는데, 상기 분쇄의 구성은 공지의 기술인바 설명의 편의 및 본 발명의 기술적 사상의 명확성을 위하여 이에 대한 구체적인 설명은 생략하기로 한다.The pulverization of the washed hemp seeds can be performed using a known pulverizer. Since the pulverization configuration is a known technology, detailed description thereof will be omitted for convenience of explanation and clarity of the technical idea of the present invention. .
그 다음으로, 상기 헴프시드 분말을 열풍 건조할 수 있다.Next, the hemp seed powder can be dried with hot air.
상기 열풍 건조는 상기 헴프시드 분말에 120 내지 140℃ 온도의 열풍을 10 내지 30분 동안 가하여 줌으로써 수행될 수 있다.The hot air drying can be performed by applying hot air at a temperature of 120 to 140° C. for 10 to 30 minutes to the hemp seed powder.
이어서, 상기 열풍 건조된 헴프시드 분말에 정제수 및 가수분해효소를 첨가하여 가수분해혼합물을 제조할 수 있다.Subsequently, a hydrolysis mixture can be prepared by adding purified water and hydrolytic enzyme to the hot air dried hemp seed powder.
상기 가수분해효소는 펙틴 가수분해효소(Pectinase) 및 탄수화물 가수분해효소(carbohydrase)의 혼합효소가 사용될 수 있는데, 예를 들어, 상기 펙틴 가수분해효소로는 펙티넥스가 사용될 수 있고, 상기 탄수화물 가수분해효소로는 비스코자임이 사용될 수 있는데, 반드시 이에 한정되는 것은 아니다.The hydrolytic enzyme may be a mixed enzyme of pectinase and carbohydrate hydrolytic enzyme. For example, Pectinex may be used as the pectin hydrolytic enzyme, and the carbohydrate hydrolysis Viscozyme may be used as an enzyme, but is not necessarily limited thereto.
상기 펙티넥스는 상용효소로서, 펙티나아제(pectinase) 및 헤미셀룰라아제(hemicellulase)의 활성을 가지는 효소이고, 상기 비스코자임은 상용효소로서, 아스퍼질러스 아큘레아투스(Aspergillus aculeatus) 유래 아라비나아제(arabinase), 셀룰라아제(cellulase), 베타-글루카나아제(beta-glucanase), 헤미셀룰라아제(hemicellulase) 및 자일라나아제(xylanase)를 포함하는 복합효소이다.The Pectinex is a commercial enzyme, and is an enzyme with the activities of pectinase and hemicellulase, and the Viscozyme is a commercial enzyme, an arabinase (Aspergillus aculeatus) derived from Aspergillus aculeatus. It is a complex enzyme containing arabinase, cellulase, beta-glucanase, hemicellulase, and xylanase.
구체적으로, 상기 가수분해혼합물은 상기 열풍 건조된 헴프시드 분말 전체 함량 100 중량부에 대해, 정제수 1250㎖와, 효소인 60unit/㎖의 비스코자임(Viscozyme) 및 550unit/㎖의 펙티넥스(Pectinex)의 혼합효소를 투입하고, 50℃에서 150rpm으로 12시간 동안 교반한 후, 37℃에서 200rpm으로 5시간 동안 교반함으로써 제조될 수 있다.Specifically, the hydrolysis mixture contains 1250 ml of purified water, 60 units/ml of Viscozyme and 550 units/ml of Pectinex as enzymes, based on 100 parts by weight of the total content of the hot air dried hemp seed powder. It can be prepared by adding mixed enzymes, stirring at 50°C at 150 rpm for 12 hours, and then stirring at 37°C at 200 rpm for 5 hours.
다음으로, 상기 가수분해혼합물을 중탕가열하여 가수분해물을 제조할 수 있다.Next, the hydrolyzate mixture can be heated in a double boiler to prepare a hydrolyzate.
상기 가수분해혼합물의 중탕가열은 공지의 중탕기를 이용하여 수행될 수 있는데, 예를 들어, 상기 가수분해물은 상기 가수분해혼합물을 50 내지 60℃ 온도에서 1 내지 5시간 동안 중탕 가열함으로써 제조될 수 있다.Heating of the hydrolysis mixture can be performed using a known bath. For example, the hydrolyzate can be prepared by heating the hydrolysis mixture at a temperature of 50 to 60° C. for 1 to 5 hours. .
상기 중탕 가열이 상기한 하한 범위 미만으로 수행되는 경우에는 가수분해 반응이 제대로 일어나지 않는 문제점이 발생할 수 있고, 상기한 상한 범위를 초과하여 수행되는 경우에는 효소의 불활성화 문제로 가수분해 반응이 완전히 일어나기 어렵고 유용성분이 변성되는 문제가 발생할 수 있다.If the bath heating is performed below the above-mentioned lower limit range, a problem may occur in which the hydrolysis reaction does not occur properly, and if it is performed beyond the above-mentioned upper limit range, the hydrolysis reaction may not occur completely due to enzyme inactivation. It is difficult and problems such as denaturation of useful components may occur.
그 다음으로, 상기 가수분해물에 발효균 배양액을 혼합한 후 발효하여 헴프시드 발효물을 제조할 수 있다.Next, fermented hemp seed product can be produced by mixing the fermentation bacteria culture with the hydrolyzate and then fermenting it.
상기 헴프시드 발효물은 상기 가수분해물 전체 함량 100 중량부에 대해, 발효균 배양액 10 내지 30 중량부의 중량 비율로 혼합한 후 60 내지 70℃의 온도에서 3 내지 7일 동안 발효시켜 제조될 수 있는데, 상기 발효균 배양액으로는 광합성세균 배양액이 이용될 수 있다.The hemp seed fermentation product can be prepared by mixing 10 to 30 parts by weight of fermentation bacteria culture with respect to 100 parts by weight of the total content of the hydrolyzate and then fermenting at a temperature of 60 to 70 ° C. for 3 to 7 days. Photosynthetic bacterial culture medium can be used as the fermenting bacteria culture medium.
예를 들어, 상기 광합성세균 배양액은, K2HPO4 0.5g, NaCl 0.1g, MgSO4·7H2O 0.2g, Na-Acetate 3g, 이스트분말(Yeast extract) 3g 및 H2O 1000㎖와, 무기원소인 CaCl2·2H2O 0.5g, FeCl·6H2O 0.025mg, CuSO4·5H2O 0.00025mg, H3BO3 0.005mg, MnCl3·4H2O 0.0003mg 및 ZnSO4·7H2O 0.005mg을 차례대로 녹여 혼합한 후 멸균하여 배양병에 넣고 로도슈도모나스 캡슐라타(Rhodopseudomonas capsulata), 로도슈도모나스 스페로이드스(Rhodopseudomonas sphaeroides) 및 로도스피릴럼 루브런(Rhodospirillum rubrum)으로 이루어진 군에서 선택된 어느 하나 이상의 광합성세균 100㎖의 균액을 접종한 후, 질소가스를 충전, 밀폐하여 혐기 상태로 만든 다음 30℃에서 2,000룩스(Lux)의 광 조건하에서 3일 동안 배양하여 제조될 수 있다.For example, the photosynthetic bacterial culture medium contains 0.5 g of K 2 HPO 4 , 0.1 g of NaCl, 0.2 g of MgSO 4 ·7H 2 O, 3 g of Na-Acetate, 3 g of yeast extract, and 1000 ml of H 2 O, The inorganic elements CaCl 2 ·2H 2 O 0.5g, FeCl·6H 2 O 0.025mg, CuSO 4 ·5H 2 O 0.00025mg, H 3 BO 3 0.005mg, MnCl 3 ·4H 2 O 0.0003mg and ZnSO 4 ·7H 2 0.005 mg of O was sequentially dissolved and mixed, sterilized, placed in a culture bottle, and any selected from the group consisting of Rhodopseudomonas capsulata , Rhodopseudomonas sphaeroides , and Rhodospirillum rubrum . It can be manufactured by inoculating 100 ml of one or more photosynthetic bacteria, filling with nitrogen gas, sealing, creating an anaerobic state, and culturing for 3 days at 30°C under light conditions of 2,000 Lux.
이어서, 상기 헴프시드 발효물을 추출한 후 여과하여 오일을 분리하고, 상기 오일을 살균처리함으로써 헴프시드 오일을 제조할 수 있다.Next, hemp seed oil can be produced by extracting the hemp seed fermentation product, filtering it to separate the oil, and sterilizing the oil.
예를 들어, 상기 헴프시드 발효물의 추출은 용매 추출법, 열수 추출법 또는 초임계 추출법과 같은 공지된 추출법을 이용할 수 있는데, 상기 추출의 구성은 당해 기술 분야에서 통상의 지식을 가진 자에게는 공지의 기술인 바, 설명의 편의 및 본 발명의 기술적 사상의 명확성을 위하여 이에 대한 구체적인 설명은 생략하기로 한다.For example, the extraction of the fermented hemp seed product can be done using known extraction methods such as solvent extraction, hot water extraction, or supercritical extraction, and the composition of the extraction is known to those skilled in the art. , for convenience of explanation and clarity of the technical idea of the present invention, detailed description thereof will be omitted.
또한, 상기 살균처리는 상기 분리된 오일을 300 내지 800 MPa 기압 및 35 내지 39℃ 온도에서 1 내지 10분 동안 비가열 초고압 살균처리를 수행함으로써 진행될 수 있는데, 상기와 같이 분리된 오일을 살균처리함으로써 가열이 수행하지 않아서 열이 인가되지 않음에 따라 제조되는 헴프시드 오일의 유용성분이 파괴되는 것을 방지할 수 있다.In addition, the sterilization treatment may be performed by performing non-heated ultra-high pressure sterilization treatment on the separated oil at 300 to 800 MPa atmospheric pressure and a temperature of 35 to 39 ° C. for 1 to 10 minutes. By sterilizing the separated oil as described above, Since heating is not performed and heat is not applied, the useful components of the hemp seed oil produced can be prevented from being destroyed.
상기 세라마이드 엔피(Ceramide NP)는 세라마이드-3(Ceramide-3)으로도 불리며 피부 장벽 성분과 매우 유사하여 피부 장벽의 개선 및 보습 지속 효과가 좋기 때문에 많은 기초 화장품에 사용되고 있다. 상기 세라마이드 엔피(Ceramide NP)의 화학구조는 하기의 [화학식 1]에 나타낸 바와 같다.The Ceramide NP is also called Ceramide-3 and is very similar to the skin barrier ingredient, so it is used in many basic cosmetics because it improves the skin barrier and has good moisturizing effects. The chemical structure of Ceramide NP is as shown in [Chemical Formula 1] below.
[화학식 1][Formula 1]
상기 세라마이드 엔피(Ceramide NP) 성분에 있어, 세라마이드는 피부 지질의 핵심 구성성분으로 피부 보호막을 형성하는데 큰 역할을 하며, 손실될 경우 피부는 건조해지고 거칠어질 수 있다. 구체적으로, 상기 세라마이드는 수분의 증발을 억제하는 지질 장벽의 역할과 각질층의 정연한 구조를 유지하게 하는 기능을 가지고 있다.Regarding the Ceramide NP ingredient, ceramide is a key component of skin lipids and plays a major role in forming a skin protective film, and if lost, the skin may become dry and rough. Specifically, the ceramide serves as a lipid barrier that suppresses evaporation of moisture and has the function of maintaining the ordered structure of the stratum corneum.
상기 글리세린은 립밤 조성물에 포함되어 수분을 흡착하여 피부에 고정시키고, 공기 중의 수분을 흡수하여 피부 건조를 방지함으로써 보습 효과를 향상시킬 수 있고, 또한, 피부 톤업 효과를 나타내어 화사한 입술 피부 표현이 가능하도록 한다.The glycerin is included in the lip balm composition and can improve the moisturizing effect by adsorbing moisture and fixing it on the skin and preventing skin drying by absorbing moisture in the air. Additionally, it has a skin tone-up effect to enable the expression of bright lip skin. do.
상기 글리세린은 분자량 92.09382g/mol, 비중 1.2644g/cm3(15℃), 녹는점 17.8℃, 끓는점 290℃이다. C3H5(OH)3의 분자식을 가진 무색무취이며 단맛이 나고 끈기가 있다. 건조방지제, 용제, 감미료로 사용되거나 음식물의 보존에 사용되기도 한다. 인체 내에서 간에서 글루코오스로 전환되어 세포대사의 에너지로 이용되며, 1g당 4.32kcal의 열량을 갖는다. 외용약(外用藥)으로 사용할 때는 희석하여 바르거나 관장제(灌腸劑)로 사용하거나 좌약(坐藥), 점활제(粘滑劑)로도 이용되며 통상사용량으로 문제가 없다.The glycerin has a molecular weight of 92.09382 g/mol, a specific gravity of 1.2644 g/cm 3 ( 15°C), a melting point of 17.8°C, and a boiling point of 290°C. It is colorless, odorless, has a molecular formula of C 3 H 5 (OH) 3 , has a sweet taste, and is sticky. It is used as an anti-drying agent, solvent, sweetener, or to preserve food. Within the human body, it is converted to glucose in the liver and used as energy for cellular metabolism, and has a caloric value of 4.32 kcal per gram. When used as an external medicine, it can be diluted and applied, used as an enema, suppository, or slimming agent, and there is no problem with normal use.
상기 바셀린은 오일 점증제로서 원유의 진공증류 잔유를 용제탈랍하여 얻어지는 연고상의 물질을 정제하여 얻을 수 있고, 주성분은 C24 ~ C43의 탄화수소로 비정질의 물질이다. 정제 정도가 높은 것으로서 화장품이나 의약품에 사용할 수 있는 백색 바셀린이 시판되고 있다.The petroleum jelly is an oil thickener that can be obtained by refining an ointment-like substance obtained by solvent dewaxing the vacuum distillation residue of crude oil, and its main component is an amorphous substance made of C24 to C43 hydrocarbons. White Vaseline, which has a high degree of purification and can be used in cosmetics and medicine, is commercially available.
상기 바셀린은 퍼스널케어 및 화장품원료로서 수분증발차단제, 피부보호제 등 매우 유의미한 효과를 주는 성분으로, 경미한 화상이나 피부 외상의 긴급 처치는 물론 습진 등의 피부질환에도 사용되는 등 전세계적으로 널리 사용되고 있다.The petroleum jelly is an ingredient that provides very significant effects as a personal care and cosmetic ingredient, such as a moisture evaporation blocker and a skin protectant. It is widely used around the world, including as an emergency treatment for minor burns or skin trauma, as well as for skin diseases such as eczema.
한편, 본 발명의 기술적 사상의 다른 실시예에 따른 립밤 조성물은, 상기 시어버터(Shea butter), 헴프시드 오일(Hempseed oil), 세라마이드 엔피(Ceramide NP), 글리세린(Glycerin) 및 바셀린(petrolatum) 이외에, 미네랄추출물을 유효성분으로 더 포함할 수도 있다.Meanwhile, the lip balm composition according to another embodiment of the technical idea of the present invention includes, in addition to the shea butter, hempseed oil, Ceramide NP, glycerin, and petrolatum. , mineral extract may be further included as an active ingredient.
즉, 본 발명의 기술적 사상의 다른 실시예에 따른 립밤 조성물은, 시어버터(Shea butter) 0.5 내지 1.5g, 헴프시드 오일(Hempseed oil) 0.3 내지 0.7㎖, 세라마이드 엔피(Ceramide NP) 0.3 내지 0.7g, 글리세린(Glycerin) 0.3 내지 0.7㎖, 바셀린(petrolatum) 0.3 내지 0.7g 및 미네랄추출물 0.1 내지 0.3g의 비율로 더 포함될 수도 있다.That is, the lip balm composition according to another embodiment of the technical idea of the present invention includes 0.5 to 1.5 g of shea butter, 0.3 to 0.7 ml of hempseed oil, and 0.3 to 0.7 g of Ceramide NP. , 0.3 to 0.7 ml of glycerin, 0.3 to 0.7 g of petrolatum, and 0.1 to 0.3 g of mineral extract.
상기 미네랄추출물은 미네랄의 유효성분이 포함된 겔 상태의 미네랄추출물일 수 있는데, 상기 미네랄은 뼈, 치아, 혈액의 구성성분이 되기도 하며 비타민과 함께 신진대사를 촉진 또는 억제하는 필수물질이다. 인체구성에 있어서 불과 3.5%밖에 되지 않는 이 미네랄이 생명현상에 작용하는 역할은 헤아릴 수 없이 큰데, 이러한 미네랄은 대별해서 다량원소와 미량원소로 나눌 수 있다.The mineral extract may be a gel-like mineral extract containing active mineral ingredients. The mineral may be a component of bones, teeth, and blood, and is an essential substance that promotes or inhibits metabolism along with vitamins. This mineral, which accounts for only 3.5% of the human body composition, plays an immeasurable role in life phenomena, and these minerals can be roughly divided into macroelements and trace elements.
예를 들어, 다량원소는 칼슘, 인, 칼륨, 유황, 나트륨, 염소, 마그네슘 등이며 이들 원소는 인체구성의 약 3%를 차지하고, 미량원소는 철, 망간, 동, 요오드, 아연, 몰리브덴, 불소, 크롬, 비소 등이며 이들 원소는 인체구성의 불과 0.5%밖에 안된다. 이들 미네랄은 인체내의 아주 적은 양밖에 존재하고 있지 않기 때문에 미량원소라고 부르는 것이다.For example, macroelements include calcium, phosphorus, potassium, sulfur, sodium, chlorine, and magnesium. These elements account for about 3% of the human body composition, and trace elements include iron, manganese, copper, iodine, zinc, molybdenum, and fluorine. , chromium, and arsenic, etc. These elements make up only 0.5% of the human body composition. These minerals are called trace elements because they exist in only very small amounts in the human body.
상기 미네랄은 피부미용, 피부질환에도 중요한 역할을 수행하는데, 상기 미네랄은 피부노화 방지, 피부세포의 수분유지, 피부 탄력 등의 효과를 발휘할 수 있고, 또한, 상기 미네랄은 천연 보습 인자(NMF: Natural Moisture Factor)의 구성 성분 중 하나로서, 세포를 활성화시키고 생리 활성 효과를 가지며 피부 보습 효과를 나타내는 것으로 알려져 있다.The mineral plays an important role in skin beauty and skin diseases. The mineral can exert effects such as preventing skin aging, maintaining moisture in skin cells, and improving skin elasticity. Additionally, the mineral is a natural moisturizing factor (NMF). As one of the components of Moisture Factor, it is known to activate cells, have physiological activity, and have a skin moisturizing effect.
예를 들어, 상기 미네랄추출물은 하기의 방법으로 제조된 미네랄추출물이 사용될 수 있다.For example, the mineral extract may be a mineral extract prepared by the following method.
먼저, 미네랄추출물을 제조하기 위하여, 천연광물을 준비할 수 있다.First, to produce a mineral extract, natural minerals can be prepared.
상기 천연광물로는 미네랄 솔트, 황옥, 황토석, 일라이트 및 감람석이 1:1:1:1:1의 중량 비율로 혼합된 혼합천연광물이 사용될 수 있다.The natural mineral may be a mixed natural mineral in which mineral salt, topaz, loess, illite, and olivine are mixed in a weight ratio of 1:1:1:1:1.
상기 미네랄 솔트는 다이아몬드와 같은 결정구조를 하고 있는 등축정계에 속하는 광물이며, 화학성분은 염화나트륨(NaCl)이다. 상기 미네랄 솔트는 대부분 무색 투명하지만 노랑, 빨강, 파랑, 보라색을 띠기도 하며 조흔색은 백색이다.The mineral salt is a mineral belonging to the equiaxed crystal system with a diamond-like crystal structure, and its chemical component is sodium chloride (NaCl). Most of the above mineral salts are colorless and transparent, but they also have yellow, red, blue, and purple colors, and the streak color is white.
상기 미네랄 솔트를 구성하는 염화나트륨은 동물에게 생리적으로 필수 불가결한 것으로 체액에 포함되어 체액의 삼투압을 조절하고, 염화나트륨의 구성 성분인 나트륨은 인산과 결합하여 완충물질로서 체액의 산염기 평형을 유지할 수 있다.Sodium chloride, which makes up the mineral salt, is physiologically essential to animals and is included in body fluids to regulate the osmotic pressure of body fluids. Sodium, a component of sodium chloride, combines with phosphoric acid and can maintain the acid-base balance of body fluids as a buffer substance. .
상기 미네랄 솔트는 섭취뿐만 아니라 피부에 도포하였을 때도 인체에 긍정적인 효과를 미치는바, 피부의 천연 보습인자 성분인 요소(urea) 보다도 우수한 피부 보습력을 가지는 것으로 보고되기도 하였으며, 각종 피부트러블 완화(피부진정), 피부 노폐물 제거 및 각질제거, 여드름, 주름, 아토피 등에도 효과가 있는 것으로 알려져 있다.The mineral salt has a positive effect on the human body not only when ingested but also when applied to the skin. It has been reported to have a superior skin moisturizing effect than urea, a natural moisturizing factor of the skin, and to alleviate various skin troubles (skin soothing). ), it is known to be effective in removing skin waste and exfoliation, acne, wrinkles, and atopic dermatitis.
상기 황옥은 감람석과 같은 결정구조를 가지는 사방정계에 속하는 광물로 토파즈(topaz)라고도 한다. 황옥은 인간 신체에 필요한 칼슘, 철분 및 마그네슘을 함유하고 있어 원적외선 방사효과가 뛰어나고 천연 자기장을 통해 체내의 불필요한 노폐물을 제거하고 산성화된 혈액을 알칼리성으로 환원시켜 생체리듬을 활성화시킨다.The topaz is a mineral belonging to the orthorhombic system that has the same crystal structure as olivine, and is also called topaz. Topaz contains calcium, iron, and magnesium necessary for the human body, so it has an excellent far-infrared radiation effect. It removes unnecessary waste from the body through a natural magnetic field and reduces acidified blood to alkaline, activating biological rhythm.
상기 황토석(loess stone)은 황토가 덩어리 상태로 수억년 동안 고체화된 것으로써, 고령토나 점토보다는 거칠고 점력이 많은 입자로서 연황색이나 분홍색을 띄고 있는 고생대의 퇴적물이다. 황토석의 주성분은 실리카와 알루미나, 철, 마그네슘, 나트륨, 카리 등 수많은 무기질을 함유한 미세입자이며, 인체에 유익한 미생물과 많은 광물약성을 갖고 있는 살아 있는 흙으로서, 원적외선과 음이온을 다량 방사한다.The loess stone is a sediment of the Paleozoic Era that is made of red clay that has solidified for hundreds of millions of years in a lumpy state, and is a light yellow or pink colored particle that is coarser and more viscous than kaolin or clay. The main components of loess stone are fine particles containing numerous minerals such as silica, alumina, iron, magnesium, sodium, and potassium. It is a living soil with microorganisms beneficial to the human body and many mineral properties, and emits a large amount of far-infrared rays and negative ions.
상기 일라이트는 다공체의 점토광물로서 원적외선과 음이온을 발생하여 항균작용과 탈취작용을 하며, 인체에 좋은 음이온 및 원적외선을 방출하기 때문에 신진대사를 촉진하고 혈액순환을 좋게 하는 등의 유용한 작용을 하는 것으로 알려져 있다.The illite is a porous clay mineral that generates far-infrared rays and negative ions to have antibacterial and deodorizing effects. It emits negative ions and far-infrared rays that are good for the human body, so it has useful effects such as promoting metabolism and improving blood circulation. It is known.
상기 감람석은 원적외선 방사효과가 뛰어나며, 상기 감람석에서 방사된 원적외선이 피부 속 40mm까지 침투하여 인체의 모세혈관을 확장시켜 혈액순환을 원활하게 하고, 신진대사를 촉진하여 독소의 배출을 도울 수 있다.The olivine has an excellent far-infrared ray radiation effect, and the far-infrared rays emitted from the olivine can penetrate up to 40 mm into the skin and expand the capillaries of the human body to facilitate blood circulation and promote metabolism to help discharge toxins.
또한, 상기 감람석은 음이온을 통해 체내 활성산소의 활동을 억제하고 노화를 방지하는 항산화작용을 하며, 혈액순환과 물질대사를 더욱 활발하게 하여 노폐물의 배출 및 면역력 증가효과를 가질 수 있다.In addition, the olivine has an antioxidant effect that suppresses the activity of free radicals in the body and prevents aging through negative ions, and can have the effect of discharging waste products and increasing immunity by making blood circulation and metabolism more active.
다음으로, 상기 준비된 천연광물을 분쇄하여 천연광물 분말을 제조할 수 있다.Next, natural mineral powder can be manufactured by grinding the prepared natural mineral.
상기 천연광물 분말은 상기 준비된 천연광물을 볼 밀링(ball milling) 장치와 같은 공지된 분쇄기로 분쇄하여 분말화함으로써 제조될 수 있는데, 분쇄기를 이용하여 분말화하는 구성은 공지의 기술인바, 설명의 편의 및 본 발명의 기술적 사상의 명확성을 위하여 이에 대한 구체적인 설명은 생략하기로 한다.The natural mineral powder can be manufactured by pulverizing the prepared natural mineral with a known grinder such as a ball milling device, and the configuration of powdering using a grinder is a known technology, for convenience of explanation. And for clarity of the technical idea of the present invention, detailed description thereof will be omitted.
다음으로, 상기 천연광물 분말을 가열하여 열처리함으로써 소성할 수 있다.Next, the natural mineral powder can be fired by heating and heat treatment.
본 발명은 상기 천연광물 분말을 소성함으로써 상기 천연광물 분말 내부에 잔류하거나 흡착된 오염물이나 불순물, 잔류 유기물 등을 제거할 수 있는데, 예를 들어, 상기 천연광물 분말의 소성은 상기 천연광물 분말을 1,300 내지 1,500℃의 온도이 소성로에서 20 내지 60분 동안 가열하여 열처리함으로써 수행될 수 있다.The present invention can remove contaminants, impurities, residual organic matter, etc. remaining or adsorbed inside the natural mineral powder by calcination of the natural mineral powder. For example, calcination of the natural mineral powder can be performed by calcination of the natural mineral powder. Heat treatment can be performed by heating at a temperature of 1,500°C to 1,500°C for 20 to 60 minutes in a furnace.
그 다음으로, 상기 소성된 천연광물 분말을 세척할 수 있다.Next, the calcined natural mineral powder can be washed.
상기 소성된 천연광물 분말을 세척함으로써 오염물들을 제거하고 부패균이나 병원균 등을 사멸시킬 수 있는데, 예를 들어, 상기 세척은 상기 소성된 천연광물 분말 전체 함량 100 중량부에 대해, 세척액 200 내지 300 중량부의 중량 비율로 혼합한 후 10 내지 30분 동안 유지하여 1차 세척하고, 이후 상기 1차 세척된 천연광물 분말을 정제수로 2차 세척하는 과정에 의해 진행될 수 있다.By washing the calcined natural mineral powder, contaminants can be removed and spoilage bacteria or pathogens can be killed. For example, the washing may be performed by using 200 to 300 parts by weight of a washing solution based on 100 parts by weight of the total content of the calcined natural mineral powder. After mixing in a weight ratio, the mixture can be kept for 10 to 30 minutes to perform primary washing, and then the primary washed natural mineral powder may be washed a second time with purified water.
상기 세척액은 살균활성이 우수하고 부패균이나 병원균을 사멸하는 효과가 우수할 수 있는데, 예를 들어, 상기 세척액은 하기의 방법으로 제조된 세척액이 사용될 수 있다.The washing liquid may have excellent sterilizing activity and an excellent effect of killing spoilage bacteria or pathogens. For example, the washing liquid prepared by the following method may be used.
먼저, 상기 세척액을 제조하기 위하여, 정제수에 구연산나트륨 및 호박산을 혼합한 후 교반하여 제1 용액을 제조할 수 있다.First, to prepare the washing solution, sodium citrate and succinic acid can be mixed with purified water and then stirred to prepare a first solution.
예를 들어, 상기 제1 용액은 정제수 100 중량부에 대해, 구연산나트륨 3 내지 7 중량부 및 호박산 1 내지 5 중량부의 중량 비율로 혼합한 후 교반하여 제조될 수 있는데, 상기 구연산나트륨은 탈취 효과, 악취 제거 효과를 향상시키고 안정성을 높이기 위하여 포함되고, 상기 호박산은 황화합물계 물질의 악취 제거 효율을 높이기 위하여 포함될 수 있다.For example, the first solution can be prepared by mixing 3 to 7 parts by weight of sodium citrate and 1 to 5 parts by weight of succinic acid with respect to 100 parts by weight of purified water and then stirring. The sodium citrate has a deodorizing effect, It is included to improve the odor removal effect and increase stability, and the succinic acid may be included to increase the odor removal efficiency of sulfur compound-based materials.
다음으로, 정제수에 에탄올 및 차아염소산(HOCl)을 혼합한 후 교반하여 제2 용액을 제조할 수 있다.Next, a second solution can be prepared by mixing ethanol and hypochlorous acid (HOCl) in purified water and then stirring.
예를 들어, 상기 제2 용액은 정제수 100 중량부에 대해, 차아염소산(HOCl) 1 내지 5 중량부의 중량 비율로 혼합한 후 교반하여 제조될 수 있다.For example, the second solution may be prepared by mixing 1 to 5 parts by weight of hypochlorous acid (HOCl) with 100 parts by weight of purified water and then stirring.
상기 차아염소산(HClO)은 차아염소산나트륨(NaOCl)에 비해서 약 70배의 살균력을 가지고 있으며, 염소계 살균제의 특징인 Tri-halo-methane(THM)을 생성하지 않기 때문에 안전하게 사용이 가능하고 한국 식품의약품안전처에서 식품용 살균제로 선정한 살균제로서 식품 산업과 농업, 의료기기 등 여러 분야에 걸쳐 사용될 수 있다.The hypochlorous acid (HClO) has approximately 70 times the sterilizing power of sodium hypochlorite (NaOCl), and can be used safely because it does not produce tri-halo-methane (THM), a characteristic of chlorine-based disinfectants, and is approved by the Korea Food and Drug Administration. It is a disinfectant selected by the Ministry of Safety and Security as a food disinfectant and can be used in various fields such as the food industry, agriculture, and medical devices.
그 다음으로, 정제수에 인산 및 이산화염소수를 혼합한 후 교반하여 제3 용액을 제조할 수 있다.Next, a third solution can be prepared by mixing purified water with phosphoric acid and chlorine dioxide solution and then stirring.
예를 들어, 상기 제3 용액은 정제수 100 중량부에 대해, 인산 1 내지 3 중량부 및 이산화염소수 5 내지 15 중량부의 중량 비율로 혼합한 후 교반함으로써 제조될 수 있다.For example, the third solution can be prepared by mixing 1 to 3 parts by weight of phosphoric acid and 5 to 15 parts by weight of chlorine dioxide solution with respect to 100 parts by weight of purified water and then stirring.
상기 인산(Phosphoric acid)은 오산화인(phosphorus pentoxide)의 가수분해로 만들어지는 산으로서, 넓은 범주에서는 인 산소산(phosphorus oxyacid)의 일종인데, 상기 인산의 원료가 되는 오산화인은 [P2O5]의 실험식으로 표기하지만, 실제 분자식은 [P4O10]이며, 하기의 [반응식 1]과 같이 백린(white phosphorus; P4)과 산소의 반응을 통해 얻을 수 있다. 이와 같은 산화 과정을 통해 인은 가장 높은 +5의 산화수를 갖게 된다.Phosphoric acid is an acid produced by hydrolysis of phosphorus pentoxide. In a broad sense, it is a type of phosphorus oxyacid. Phosphoric acid, which is the raw material of phosphorus pentoxide, is [P 2 O 5 ]. Although it is expressed as an empirical formula, the actual molecular formula is [P 4 O 10 ], and can be obtained through the reaction of white phosphorus (P 4 ) and oxygen as shown in [Reaction Scheme 1] below. Through this oxidation process, phosphorus has the highest oxidation number of +5.
[반응식 1][Scheme 1]
[반응식 2][Scheme 2]
상기 [반응식 2]를 참조하면, 오산화인 가수분해 반응의 생성물인 H3PO4는 인산의 가장 단순한 형태로 오쏘인산(orthophosphoric acid, 또는 오르토인산)이라고 부르며, 상기 오쏘인산 두 분자의 축합반응으로 파이로인산(pyrophosphoric acid, ; 피로인산, 이인산, 혹은 초성인산으로도 불린다)이 얻어질 수 있다.Referring to [Reaction Scheme 2] above, H 3 PO 4 , the product of the phosphorus pentoxide hydrolysis reaction, is the simplest form of phosphoric acid and is called orthophosphoric acid (orthophosphoric acid), and is formed by a condensation reaction of the two orthophosphoric acid molecules. Pyrophosphoric acid (also called pyrophosphoric acid, diphosphoric acid, or acetic phosphoric acid) can be obtained.
정제된 인산은 상온에서 결정성이 있는 고체(녹는점: 42.3℃)로 밀도는 2.030g/cm3(25℃ 기준)이고, 인산은 446g/100mL 정도로 물에 녹으며(14.95℃ 기준), 수용액에서 삼양성자산(triprotic acid)으로 작용하여 양성자를 세 개까지 내놓고, H3PO4 -, HPO4 2-, PO4 3-의 세 가지 음이온을 만들 수 있다.Purified phosphoric acid is a crystalline solid at room temperature (melting point: 42.3℃) and has a density of 2.030g/cm 3 (based on 25℃). Phosphoric acid dissolves in water at approximately 446g/100mL (based on 14.95℃) and is an aqueous solution. It acts as a triprotic acid, giving up to three protons, and can create three anions: H 3 PO 4 - , HPO 4 2 - , and PO 4 3 - .
상기 이산화염소수(aqueous chlorine dioxide)는 예를 들어, 파우더 형태의 아염소산나트륨 및 염화수소 용액을 이용하여 제조할 수 있으며, 아염소나트륨 용액 및 염화수소 용액을 이용하여 제조할 수 있으나 이에 한정되지 않고, 또한, 상기 이산화염소수는 50 내지 150ppm의 농도일 수 있다.The aqueous chlorine dioxide can be prepared, for example, using powdered sodium chlorite and hydrogen chloride solutions, and can be prepared using sodium chlorine solution and hydrogen chloride solution, but is not limited to this. Additionally, the chlorine dioxide solution may have a concentration of 50 to 150 ppm.
상기 이산화염소수는 독성이 강하지 않고 안전하며 오염을 일으키지 않아 친환경적이며, 강한 산화작용의 특징을 지님에 따라 정수의 살균처리제나 종이 섬유 식품 등의 표백제 또는 탈취제로 사용되고 있다.The chlorine dioxide water is not highly toxic, is safe, and does not cause pollution, so it is environmentally friendly. Since it has a strong oxidizing effect, it is used as a sterilizing agent for purified water or as a bleaching agent or deodorizer for paper, fiber, and food.
이어서, 상기 제1 용액, 제2 용액 및 제3 용액의 혼합액에 자몽종자추출물을 혼합한 후 교반하여 세척액을 제조할 수 있다.Subsequently, a washing solution can be prepared by mixing grapefruit seed extract with the mixed solution of the first solution, second solution, and third solution and then stirring.
예를 들어, 상기 혼합액은 제1 용액 40 중량부, 제2 용액 30 중량부 및 제3 용액 20 중량부의 중량 비율로 혼합되어 제조될 수 있고, 상기 세척액은 상기 혼합액 100 중량부에 대해, 자몽종자추출물 10 중량부의 중량 비율로 혼합되어 제조될 수 있다.For example, the mixed solution may be prepared by mixing 40 parts by weight of the first solution, 30 parts by weight of the second solution, and 20 parts by weight of the third solution, and the washing solution may be prepared by mixing grapefruit seeds with respect to 100 parts by weight of the mixed solution. It can be prepared by mixing the extract at a weight ratio of 10 parts by weight.
상기 천연추출액은 항균성, 탈취성 등의 효과를 제공할 수 있는데, 상기 천연추출액은 편백나무 및 자몽종자로 이루어진 재료들을 혼합한 후 추출하여 제조될 수 있다.The natural extract can provide effects such as antibacterial and deodorizing properties. The natural extract can be prepared by mixing ingredients made of cypress and grapefruit seeds and then extracting them.
상기 자몽종자추출물은 자몽종자를 추출하여 제조될 수 있는데, 상기 자몽종자는 주성분으로 아스코르브산, 스테롤, 데하이드로 아스코르브산, 토코페롤, 팔미트산 등을 포함하며, 다양한 유효성분이 미생물의 세포막 관련 효소 활성 및 투과성을 약화시키며 세포 호흡 작용을 억제시켜 미생물의 생육을 저해하는 것으로 알려져 있다.The grapefruit seed extract can be prepared by extracting grapefruit seeds. The grapefruit seeds contain ascorbic acid, sterol, dehydroascorbic acid, tocopherol, palmitic acid, etc. as main ingredients, and various active ingredients inhibit the enzyme activity related to the cell membrane of microorganisms. It is known to inhibit the growth of microorganisms by weakening permeability and inhibiting cellular respiration.
특히, 상기 자몽종자는 바이오플라보노이드인 나린진 및 시트랄을 주성분으로 포함하므로 항균 및 항산화작용이 뛰어날 뿐만 아니라, 그램-양성 및 그램-음성균 뿐만 아니라 곰팡이에 대한 항균작용이 우수하다.In particular, the grapefruit seeds contain bioflavonoids naringin and citral as main ingredients, so they not only have excellent antibacterial and antioxidant effects, but also have excellent antibacterial effects against gram-positive and gram-negative bacteria as well as mold.
이어서, 상기 세척된 천연광물 분말에 정제수를 혼합하여 가열한 후 보관하여 숙성하고, 상기 정제수에서 천연광물 분말을 분리하여 제거함으로써, 미네랄 성분이 포함된 침출액을 제조할 수 있다.Next, purified water is mixed with the washed natural mineral powder, heated, stored and aged, and the natural mineral powder is separated and removed from the purified water, thereby producing a leachate containing mineral components.
상기 침출액은 상기 세척된 천연광물 분말 전체 함량 100 중량부에 대해, 정제수 2,000 내지 3,000 중량부의 중량 비율로 혼합한 후 90 내지 95℃ 온도에서 5 내지 10시간 동안 가열하고, 이후 40 내지 50℃ 온도에서 3 내지 7일 동안 보관하여 숙성한 후, 고형분인 천연광물 분말을 분리하여 제거함으로써 제조될 수 있다.The leachate is mixed at a weight ratio of 2,000 to 3,000 parts by weight of purified water based on 100 parts by weight of the total content of the washed natural mineral powder, heated at a temperature of 90 to 95 ° C. for 5 to 10 hours, and then heated at a temperature of 40 to 50 ° C. It can be manufactured by storing and maturing for 3 to 7 days, then separating and removing the solid natural mineral powder.
다음으로, 상기 침출액을 원심분리한 후 상층액을 분리할 수 있다.Next, the leachate can be centrifuged and the supernatant can be separated.
상기 침출액에는 천연광물의 유효성분들이 침출되어 있는데, 상기 침출액을 원심분리함으로써, 천연광물의 미세입자들이 위치하는 하층액과, 상기 하층액 상부에 위치하는 중층액 및 상층액으로 위치적으로 구분하여 분리할 수 있다.The active ingredients of natural minerals are leached in the leachate. By centrifuging the leachate, it is geographically divided into a lower layer liquid where fine particles of natural minerals are located, a middle layer liquid located on top of the lower layer liquid, and a supernatant liquid. It can be separated.
그 다음으로, 상기 분리된 상층액을 가열함으로써 미네랄추출물을 제조할 수 있다.Next, a mineral extract can be prepared by heating the separated supernatant.
상기 미네랄추출물은 상기 원심분리된 상층액을 110 내지 120℃ 온도로 가열하여 수분을 제거함으로써 천연광물의 유효성분들이 침출되어 형성된 겔 상태의 미네랄추출물을 제조할 수 있다.The mineral extract can be prepared by heating the centrifuged supernatant to a temperature of 110 to 120° C. to remove moisture, thereby producing a gel-like mineral extract formed by leaching the active ingredients of natural minerals.
이하, 첨부된 도면을 참조하여 본 발명의 기술적 사상의 일 실시예에 따른 립밤 조성물에 대한 실시예 및 비교예를 들어 더욱 구체적으로 설명하기로 한다.Hereinafter, a lip balm composition according to an embodiment of the technical idea of the present invention will be described in more detail through examples and comparative examples with reference to the attached drawings.
< 실시예 1 ><Example 1>
시어버터(Shea butter) 1g, 헴프시드 오일(Hempseed oil) 0.5㎖, 세라마이드 엔피(Ceramide NP) 0.5g, 글리세린(Glycerin) 0.5㎖, 바셀린(petrolatum) 0.5g, 비즈왁스 8g, 하이드로제네이티드폴리아이소부텐 7g, 다이아이소스테아릴말레이트 5g, 옥틸도데칸올 4g, 세레신 2g, 마이크로크리스탈린왁스 1.5g, 올리브오일 2g, 호호바오일 4g, 폴리에틸렌 4.5g, 아이소프로필미리스테이트 0.2g, 토코페릴아세테이트 0.2g, 카프릴릴글라이콜 0.1g, 솔비탄세스퀴올리에이트 0.1g, 리모넨 0.2g, 아스코빅애씨드 0.3g, 향료 0.04g 및 1.2-헥산디올 15g을 혼합하여 립밤을 제조하였다.Shea butter 1g, Hempseed oil 0.5ml, Ceramide NP 0.5g, Glycerin 0.5ml, Vaseline 0.5g, Beeswax 8g, Hydrogenated polyisobu Ten 7g, diisostearyl maleate 5g, octyldodecanol 4g, ceresin 2g, microcrystalline wax 1.5g, olive oil 2g, jojoba oil 4g, polyethylene 4.5g, isopropyl myristate 0.2g, tocopheryl acetate 0.2 A lip balm was prepared by mixing 0.1 g of caprylyl glycol, 0.1 g of sorbitan sesquioleate, 0.2 g of limonene, 0.3 g of ascorbic acid, 0.04 g of fragrance, and 15 g of 1.2-hexanediol.
< 실시예 2 ><Example 2>
시어버터(Shea butter) 0.8g, 헴프시드 오일(Hempseed oil) 0.6㎖, 세라마이드 엔피(Ceramide NP) 0.4g, 글리세린(Glycerin) 0.6㎖, 바셀린(petrolatum) 0.4g, 비즈왁스 8g, 하이드로제네이티드폴리아이소부텐 7g, 다이아이소스테아릴말레이트 5g, 옥틸도데칸올 4g, 세레신 2g, 마이크로크리스탈린왁스 1.5g, 올리브오일 2g, 호호바오일 4g, 폴리에틸렌 4.5g, 아이소프로필미리스테이트 0.2g, 토코페릴아세테이트 0.2g, 카프릴릴글라이콜 0.1g, 솔비탄세스퀴올리에이트 0.1g, 리모넨 0.2g, 아스코빅애씨드 0.3g, 향료 0.04g 및 1.2-헥산디올 15g을 혼합하여 립밤을 제조하였다.Shea butter 0.8g, Hempseed oil 0.6ml, Ceramide NP 0.4g, Glycerin 0.6ml, Vaseline (petrolatum) 0.4g, Beeswax 8g, Hydrogenated Polya Isobutene 7g, diisostearyl maleate 5g, octyldodecanol 4g, ceresin 2g, microcrystalline wax 1.5g, olive oil 2g, jojoba oil 4g, polyethylene 4.5g, isopropyl myristate 0.2g, tocopheryl acetate Lip balm was prepared by mixing 0.2g, 0.1g of caprylyl glycol, 0.1g of sorbitan sesquioleate, 0.2g of limonene, 0.3g of ascorbic acid, 0.04g of fragrance, and 15g of 1.2-hexanediol.
< 실시예 3 ><Example 3>
시어버터(Shea butter) 1.3g, 헴프시드 오일(Hempseed oil) 0.4㎖, 세라마이드 엔피(Ceramide NP) 0.6g, 글리세린(Glycerin) 0.4㎖, 바셀린(petrolatum) 0.6g, 미네랄추출물 0.2g, 비즈왁스 8g, 하이드로제네이티드폴리아이소부텐 7g, 다이아이소스테아릴말레이트 5g, 옥틸도데칸올 4g, 세레신 2g, 마이크로크리스탈린왁스 1.5g, 올리브오일 2g, 호호바오일 4g, 폴리에틸렌 4.5g, 아이소프로필미리스테이트 0.2g, 토코페릴아세테이트 0.2g, 카프릴릴글라이콜 0.1g, 솔비탄세스퀴올리에이트 0.1g, 리모넨 0.2g, 아스코빅애씨드 0.3g, 향료 0.04g 및 1.2-헥산디올 15g을 혼합하여 립밤을 제조하였다.Shea butter 1.3g, Hempseed oil 0.4ml, Ceramide NP 0.6g, Glycerin 0.4ml, Vaseline (petrolatum) 0.6g, Mineral extract 0.2g, Beeswax 8g , Hydrogenated polyisobutene 7g, diisostearyl malate 5g, octyldodecanol 4g, ceresin 2g, microcrystalline wax 1.5g, olive oil 2g, jojoba oil 4g, polyethylene 4.5g, isopropyl myristate 0.2 g, 0.2g of tocopheryl acetate, 0.1g of caprylyl glycol, 0.1g of sorbitan sesquioleate, 0.2g of limonene, 0.3g of ascorbic acid, 0.04g of fragrance, and 15g of 1.2-hexanediol to prepare lip balm. did.
< 비교예 ><Comparative example>
비즈왁스 8g, 하이드로제네이티드폴리아이소부텐 7g, 다이아이소스테아릴말레이트 5g, 옥틸도데칸올 4g, 세레신 2g, 마이크로크리스탈린왁스 1.5g, 올리브오일 2g, 호호바오일 4g, 폴리에틸렌 4.5g, 아이소프로필미리스테이트 0.2g, 토코페릴아세테이트 0.2g, 카프릴릴글라이콜 0.1g, 솔비탄세스퀴올리에이트 0.1g, 리모넨 0.2g, 아스코빅애씨드 0.3g, 향료 0.04g 및 1.2-헥산디올 15g을 혼합하여 립밤을 제조하였다.8g beeswax, 7g hydrogenated polyisobutene, 5g diisostearyl maleate, 4g octyldodecanol, 2g ceresin, 1.5g microcrystalline wax, 2g olive oil, 4g jojoba oil, 4.5g polyethylene, isopropyl Mix 0.2g myristate, 0.2g tocopheryl acetate, 0.1g caprylyl glycol, 0.1g sorbitan sesquioleate, 0.2g limonene, 0.3g ascorbic acid, 0.04g fragrance, and 15g 1.2-hexanediol. Lip balm was manufactured.
< 실험예 ><Experimental example>
실시예 1, 2, 3과 비교예에 따라 제조된 립밤 시료를 이용하여 실험을 수행하였다.An experiment was performed using lip balm samples prepared according to Examples 1, 2, and 3 and Comparative Examples.
1. 립밤의 제형 안정성 실험1. Formulation stability test of lip balm
실시예 1, 2, 3과 비교예에 따라 제조된 립밤의 제형 안정성 실험을 수행하였다.Formulation stability tests were conducted on lip balms prepared according to Examples 1, 2, and 3 and Comparative Examples.
관찰 기간은 1주일 동일 실시하였으며, 다양한 온도에서 안정성을 관찰하였고, 그 결과를 [표 1]에 나타내었다.The observation period was the same for one week, and stability was observed at various temperatures, and the results are shown in [Table 1].
상기 [표 1]을 참조하면, 실시예 1, 2, 3과 비교예에 따라 제조된 립밤은 제형 안정성이 양호한 것을 확인할 수 있었다.Referring to [Table 1], it was confirmed that the lip balms prepared according to Examples 1, 2, and 3 and Comparative Examples had good formulation stability.
2. 항산화활성 실험2. Antioxidant activity test
실시예 1, 2, 3과 비교예에 따라 제조된 립밤 시료를 이용하여 라디칼 소거 활성능을 측정하였다.The radical scavenging activity was measured using lip balm samples prepared according to Examples 1, 2, and 3 and Comparative Examples.
시료의 항산화 활성(electron donation ability, EDA%)은 Blois의 방법을 변형하여 측정하였다. 시료 2mL에 0.2mM의 DPPH(1,1-diphenyl-2-picryl hydrazyl) 용액 2mL를 혼합한 후 30분간 방치한 다음 517nm에서 흡광도를 측정하였다.The antioxidant activity (electron donating ability, EDA%) of the sample was measured by modifying Blois' method. 2 mL of 0.2mM DPPH (1,1-diphenyl-2-picryl hydrazyl) solution was mixed with 2 mL of the sample, left for 30 minutes, and then the absorbance was measured at 517 nm.
라디칼 소거 활성능은 시료 첨가구와 무첨가구의 흡광도 감소율로 나타내었다. 라디칼 소거 활성능은 다음과 같은 식에 의해 계산하여 그 결과를 하기 [표 2]에 나타내었다. 대조구의 시료로 BHT(합성산화방지제)를 이용하였다.The radical scavenging activity was expressed as the rate of decrease in absorbance between the sample addition and no sample additions. The radical scavenging activity was calculated using the following equation, and the results are shown in [Table 2] below. BHT (synthetic antioxidant) was used as a control sample.
라디칼소거활성능(%) = (1 - 시료첨가구의 흡광도/무첨가구의 흡광도)×100Radical scavenging activity (%) = (1 - Absorbance of sample added / Absorbance of no sample added) x 100
상기 [표 2]를 참조하면, 실시예 1, 2, 3에 따라 제조된 립밤은 비교예에 따라 제조된 립밤에 비해 항산화 활성이 우수한 것을 알 수 있고, 대조구로 사용된 통상적인 합성산화방지제의 라디칼 소거능 보다 우수한 효과를 갖는 것으로 확인되었다.Referring to [Table 2], it can be seen that the lip balm prepared according to Examples 1, 2, and 3 has superior antioxidant activity compared to the lip balm prepared according to the comparative example, and that the lip balm prepared according to Examples 1, 2, and 3 has excellent antioxidant activity compared to the lip balm prepared according to the comparative example. It was confirmed to have a superior effect than radical scavenging ability.
따라서 실시예 1, 2, 3에 따라 제조된 립밤은 활성산소 및 자유라디칼로부터 피부를 보호하는 항산화 효과가 우수하며 피부의 생리활성을 크게 강화시킬 것으로 기대된다.Therefore, the lip balm prepared according to Examples 1, 2, and 3 is expected to have an excellent antioxidant effect that protects the skin from active oxygen and free radicals and to greatly enhance the physiological activity of the skin.
3. 보습효과 측정3. Measurement of moisturizing effect
코르네오메타(Corneometer) CM820(독일 Courage)을 이용한 커패시턴스 측정법을 사용하고, 시료는 실시예 1, 2, 3과 비교예에 따라 제조된 립밤을 사용하여 보습효과를 비교 측정하였다.A capacitance measurement method using Corneometer CM820 (Courage, Germany) was used, and the moisturizing effect was compared and measured using lip balms prepared according to Examples 1, 2, and 3 and Comparative Examples.
대한민국 남녀 각각 6명씩 전체 30명을 대상으로 하여, 시험 시작 직전 하박 내측면을 대상으로 항온항습실에서 20분 동안 적응하게 한 다음, 피부 수분을 일정하게 유지시켰다. 그 다음, 코르네오메타 C820을 사용하여 각 시료 도포부위의 초기 수분 보유 양을 측정한 후, 실시예 1, 2, 3과 비교예에 따라 제조된 립밤을 도포하였다. A total of 30 Korean people, 6 men and 6 men, were tested. Just before starting the test, the inner side of the lower arm was allowed to acclimatize in a constant temperature and humidity room for 20 minutes, and then the skin moisture was maintained at a constant level. Next, the initial moisture retention amount of each sample application site was measured using Corneometer C820, and then the lip balm prepared according to Examples 1, 2, and 3 and Comparative Example was applied.
도포 30분 후에 수분증감율을 1차 측정하고, 2시간 30분 후 다시 수분증감율을 측정하였다. 각 측정부위를 3번 반복 측정하고 그 평균값으로 하기 [수학식 1]에 따라 피부 수분 증감율을 계산하여 [표 3]에 나타내었다.The moisture increase and decrease rate was first measured 30 minutes after application, and the moisture increase and decrease rate was measured again after 2 hours and 30 minutes. Each measurement site was measured three times, and the average value was used to calculate the skin moisture increase/decrease rate according to the following [Equation 1], which is shown in [Table 3].
[수학식 1][Equation 1]
수분증감율(%) = (Tdi-Tdo)-(Ntdi-NTdo) / ((Ntdi-Ntdo) + Tdo) * 100Moisture increase/decrease rate (%) = (Tdi-Tdo)-(Ntdi-NTdo) / ((Ntdi-Ntdo) + Tdo) * 100
Tdi : 시료 도포 부위의 n번째 측정값Tdi: nth measurement value of sample application area
Tdo : 시료 도포 전 측정값Tdo: Measured value before sample application
Ntdi : 시료를 도포하지 않은 부위의 n번째 측정값Ntdi: nth measurement value of the area where the sample was not applied
NTdo : 시료를 도포하지 않은 부위의 도포 전 측정값NTdo: Measured value before application of the area where the sample was not applied
상기 [표 3]을 참조하면, 실시예 1, 2, 3에 따라 제조된 립밤이 비교예에 따라 제조된 립밤에 비해 초기뿐만 아니라 시간이 경과하여도 보습효과가 우수함을 확인할 수 있었다.Referring to [Table 3], it was confirmed that the lip balm prepared according to Examples 1, 2, and 3 had an excellent moisturizing effect not only initially but also over time compared to the lip balm prepared according to the comparative example.
4. 립밤의 자극 실험4. Lip balm stimulation experiment
실시예 1, 2, 3과 비교예에 따라 제조된 립밤에 대한 자극 실험을 다음과 같이 실시하였다.Irritation tests were conducted on lip balms prepared according to Examples 1, 2, and 3 and Comparative Examples as follows.
먼저, 임상실험은 20세에서 50세 사이의 건강한 여성 35명을 대상으로 하였는데, 비누 세안 후, 화장품이나 보습제 등을 바르지 않고 실시예 1, 2, 3과 비교예에 따라 제조된 립밤을 피험자의 입술에 도포하여 건조한 후 100분 후에 피부 상태(홍반, 부종, 구진 등)를 관찰하여 하기 [표 4]와 같은 평가표를 통한 정성적 평가를 수행하였다.First, the clinical experiment was conducted on 35 healthy women between the ages of 20 and 50. After washing their face with soap, they applied lip balm prepared according to Examples 1, 2, and 3 and Comparative Example without applying cosmetics or moisturizers. After applying to the lips and drying, the skin condition (erythema, edema, papules, etc.) was observed 100 minutes later and a qualitative evaluation was performed using the evaluation table shown in [Table 4] below.
자극 정도
degree of stimulation
상기 [표 4]의 자극 정도에 대한 실험 대상자의 평가 결과는 하기의 [표 5]와 같다.The test subjects' evaluation results for the degree of stimulation in [Table 4] are shown in [Table 5] below.
자극 정도
degree of stimulation
상기 [표 5]를 참조하면, 실시예 1, 2, 3과 비교예에 따라 제조된 립밤은 자극이나 피부상태 변화가 거의 없는 것으로 홍반, 부종 등의 자극이 거의 없는 안전한 물질임을 확인할 수 있었다.Referring to [Table 5], the lip balms prepared according to Examples 1, 2, and 3 and Comparative Examples showed little irritation or change in skin condition, confirming that they were safe materials with little irritation such as erythema or edema.
5. 관능 평가5. Sensory evaluation
실시예 1, 2, 3과 비교예에 따라 제조된 립밤에 대한 발림성, 색도, 향, 수분감, 선호도 등에 대하여 관능평가를 실시하였으며, 그 결과를 아래 [표 7]에 나타내었다.Sensory evaluation was conducted on the lip balms prepared according to Examples 1, 2, and 3 and Comparative Examples for spreadability, color, fragrance, moisture, preference, etc., and the results are shown in [Table 7] below.
관능시험은 일반 여성 소비자(20세에서 50세 사이) 50명을 대상으로 실시하고, 점수 및 평가기준은 9점 채점법을 이용하였으며, 아래 [표 6]에 나타내었다.The sensory test was conducted on 50 general female consumers (between the ages of 20 and 50), and the scores and evaluation criteria used a 9-point scoring method and are shown in [Table 6] below.
상기 [표 7]을 참조하면, 실시예 1, 2, 3에 따라 제조된 립밤이 비교예에 따라 제조된 립밤에 비해 발림성, 색도, 향, 수분감, 기호도가 우수한 것을 확인할 수 있다.Referring to [Table 7], it can be seen that the lip balm prepared according to Examples 1, 2, and 3 is superior to the lip balm prepared according to the comparative example in terms of spreadability, color, fragrance, moisture, and preference.
이상, 첨부된 도면을 참조하여 본 발명의 바람직한 일 실시예를 설명하였지만, 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자라면 본 발명이 그 기술적 사상이나 필수적인 특징을 변경하지 않고서 다른 구체적인 형태로 실시될 수 있다는 것을 이해할 수 있을 것이다. 그러므로 이상에서 기술한 일 실시예는 모든 면에서 예시적인 것이며 한정적이 아닌 것으로 이해해야만 한다.Above, a preferred embodiment of the present invention has been described with reference to the attached drawings, but those skilled in the art will understand that the present invention can be modified in another specific form without changing its technical idea or essential features. You will understand that it can be done. Therefore, the embodiment described above should be understood as illustrative in all respects and not restrictive.
Claims (6)
상기 세라마이드 엔피(Ceramide NP)는 평균 입자 크기가 0.05 내지 2.5㎛이고, 상기 세라마이드 엔피(Ceramide NP)는 0.5% 세라마이드 엔피(Ceramide NP) 수용액이 사용되며,
상기 헴프시드 오일은, 헴프시드를 준비한 후 세척하고, 상기 세척된 헴프시드를 분쇄하여 헴프시드 분말을 제조하며, 상기 헴프시드 분말에 120 내지 140℃ 온도의 열풍을 10 내지 30분 동안 가하여 줌으로써 열풍 건조하고, 상기 열풍 건조된 헴프시드 분말 전체 함량 100 중량부에 대해, 정제수 1250㎖와, 효소인 60unit/㎖의 비스코자임(Viscozyme) 및 550unit/㎖의 펙티넥스(Pectinex)의 혼합효소를 투입하고, 50℃에서 150rpm으로 12시간 동안 교반한 후, 37℃에서 200rpm으로 5시간 동안 교반함으로써 가수분해혼합물을 제조하며, 상기 가수분해혼합물을 50 내지 60℃ 온도에서 1 내지 5시간 동안 중탕가열하여 가수분해물을 제조하고, 상기 가수분해물 전체 함량 100 중량부에 대해, 발효균 배양액 10 내지 30 중량부의 중량 비율로 혼합한 후 60 내지 70℃의 온도에서 3 내지 7일 동안 발효시켜 헴프시드 발효물을 제조하며, 상기 헴프시드 발효물을 추출한 후 여과하여 오일을 분리하고, 상기 오일을 살균처리함으로써 제조된 헴프시드 오일이 사용되며,
상기 미네랄추출물은, 미네랄 솔트, 황옥, 황토석, 일라이트 및 감람석이 1:1:1:1:1의 중량 비율로 혼합된 혼합천연광물을 준비하고, 상기 준비된 천연광물을 분쇄하여 천연광물 분말을 제조하며, 상기 천연광물 분말을 1,300 내지 1,500℃의 온도이 소성로에서 20 내지 60분 동안 가열하여 열처리함으로써 소성하고, 상기 소성된 천연광물 분말 전체 함량 100 중량부에 대해, 세척액 200 내지 300 중량부의 중량 비율로 혼합한 후 10 내지 30분 동안 유지하여 1차 세척하고, 이후 상기 1차 세척된 천연광물 분말을 정제수로 2차 세척하며, 상기 세척된 천연광물 분말 전체 함량 100 중량부에 대해, 정제수 2,000 내지 3,000 중량부의 중량 비율로 혼합한 후 90 내지 95℃ 온도에서 5 내지 10시간 동안 가열하고, 이후 40 내지 50℃ 온도에서 3 내지 7일 동안 보관하여 숙성한 후, 고형분인 천연광물 분말을 분리하여 제거함으로써 침출액을 제조하며, 상기 침출액을 원심분리함으로써, 천연광물의 미세입자들이 위치하는 하층액과, 상기 하층액 상부에 위치하는 중층액 및 상층액으로 위치적으로 구분한 후 상기 상층액을 분리하고, 상기 분리된 상층액을 110 내지 120℃ 온도로 가열하여 수분을 제거함으로써 제조되며,
상기 세척액은 정제수 100 중량부에 대해, 구연산나트륨 3 내지 7 중량부 및 호박산 1 내지 5 중량부의 중량 비율로 혼합한 후 교반하여 제1 용액을 제조하고, 정제수 100 중량부에 대해, 차아염소산(HOCl) 1 내지 5 중량부의 중량 비율로 혼합한 후 교반하여 제2 용액을 제조하며, 정제수 100 중량부에 대해, 인산 1 내지 3 중량부 및 이산화염소수 5 내지 15 중량부의 중량 비율로 혼합한 후 교반하여 제3 용액을 제조하고, 상기 제1 용액 40 중량부, 제2 용액 30 중량부 및 제3 용액 20 중량부의 중량 비율로 혼합하여 혼합액을 제조하며, 상기 혼합액 100 중량부에 대해, 자몽종자추출물 10 중량부의 중량 비율로 혼합하여 제조된 세척액인 것을 특징으로 하는 립밤 조성물.
Shea butter 1.3g, Hempseed oil 0.4ml, Ceramide NP 0.6g, Glycerin 0.4ml, Vaseline (petrolatum) 0.6g, Mineral extract 0.2g, Beeswax 8g , Hydrogenated polyisobutene 7g, diisostearyl malate 5g, octyldodecanol 4g, ceresin 2g, microcrystalline wax 1.5g, olive oil 2g, jojoba oil 4g, polyethylene 4.5g, isopropyl myristate 0.2 g, tocopheryl acetate 0.2g, caprylyl glycol 0.1g, sorbitan sesquioleate 0.1g, limonene 0.2g, ascorbic acid 0.3g, fragrance 0.04g and 1.2-hexanediol 15g,
The Ceramide NP has an average particle size of 0.05 to 2.5㎛, and a 0.5% aqueous solution of Ceramide NP is used.
The hemp seed oil is prepared by preparing hemp seeds, washing them, grinding the washed hemp seeds to prepare hemp seed powder, and applying hot air at a temperature of 120 to 140 ° C. for 10 to 30 minutes to the hemp seed powder. After drying, 1250 ml of purified water and a mixed enzyme of 60 units/ml of Viscozyme and 550 units/ml of Pectinex were added to the total content of 100 parts by weight of the hot air dried hemp seed powder. , A hydrolysis mixture is prepared by stirring at 150 rpm at 50°C for 12 hours and then at 37°C for 5 hours at 200 rpm, and the hydrolysis mixture is heated in a bath at a temperature of 50 to 60°C for 1 to 5 hours to produce hydrolysis. The decomposition product is prepared, mixed at a weight ratio of 10 to 30 parts by weight of fermentation bacteria culture based on 100 parts by weight of the total content of the hydrolyzate, and then fermented at a temperature of 60 to 70 ° C. for 3 to 7 days to produce a hemp seed fermentation product. , Hemp seed oil prepared by extracting the hemp seed fermentation product, filtering it to separate the oil, and sterilizing the oil is used,
The mineral extract is prepared by preparing a mixed natural mineral in which mineral salt, topaz, loess, illite, and olivine are mixed in a weight ratio of 1:1:1:1:1, and grinding the prepared natural mineral to obtain natural mineral powder. Manufactured, the natural mineral powder is calcined by heat treatment by heating in a kiln at a temperature of 1,300 to 1,500°C for 20 to 60 minutes, and a weight ratio of 200 to 300 parts by weight of the washing liquid is used based on 100 parts by weight of the total content of the calcined natural mineral powder. After mixing, it is maintained for 10 to 30 minutes for primary washing, and then the primary washed natural mineral powder is secondary washed with purified water, and based on 100 parts by weight of the total content of the washed natural mineral powder, 2,000 to 2,000 to 100 parts by weight of purified water is added. After mixing at a weight ratio of 3,000 parts by weight, it is heated at a temperature of 90 to 95 ℃ for 5 to 10 hours, and then stored and aged at a temperature of 40 to 50 ℃ for 3 to 7 days, and then the solid natural mineral powder is separated and removed. A leachate is prepared by centrifuging the leachate to separate it into a lower layer containing fine particles of natural minerals, a middle layer and a supernatant located on top of the lower layer, and then separating the supernatant. , prepared by removing moisture by heating the separated supernatant to a temperature of 110 to 120°C,
The washing liquid is mixed at a weight ratio of 3 to 7 parts by weight of sodium citrate and 1 to 5 parts by weight of succinic acid with respect to 100 parts by weight of purified water and then stirred to prepare a first solution, and hypochlorous acid (HOCl) is added to 100 parts by weight of purified water. ) 1 to 5 parts by weight are mixed and then stirred to prepare a second solution, and 1 to 3 parts by weight of phosphoric acid and 5 to 15 parts by weight of chlorine dioxide are mixed with 100 parts by weight of purified water and then stirred. A third solution is prepared, and a mixed solution is prepared by mixing 40 parts by weight of the first solution, 30 parts by weight of the second solution, and 20 parts by weight of the third solution in a weight ratio, and for 100 parts by weight of the mixed solution, grapefruit seed extract is added. A lip balm composition, characterized in that it is a washing liquid prepared by mixing at a weight ratio of 10 parts by weight.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020230074765A KR102641072B1 (en) | 2023-06-12 | 2023-06-12 | Lip balm composition and lip balm prepared including the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020230074765A KR102641072B1 (en) | 2023-06-12 | 2023-06-12 | Lip balm composition and lip balm prepared including the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR102641072B1 true KR102641072B1 (en) | 2024-02-28 |
Family
ID=90052857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020230074765A KR102641072B1 (en) | 2023-06-12 | 2023-06-12 | Lip balm composition and lip balm prepared including the same |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR102641072B1 (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20200035485A (en) * | 2015-10-29 | 2020-04-03 | 글락소스미스클라인 컨슈머 헬스케어 홀딩스 (유에스) 엘엘씨 | Novel occlusive compositions |
| KR20200046060A (en) * | 2015-10-29 | 2020-05-06 | 글락소스미스클라인 컨슈머 헬스케어 홀딩스 (유에스) 엘엘씨 | Novel occlusive formulations |
| KR102461841B1 (en) | 2022-05-25 | 2022-11-02 | 주식회사 네츄럴샤인 | Lip balm composition for lip protection that provides double moisturizing |
| KR102518286B1 (en) | 2020-10-28 | 2023-04-05 | 코스맥스 주식회사 | Cosmetic composition for manufacturing stick typed lip balm and stick typed lip balm having an enhanced usability and functionality manufactured by the same |
| KR102535756B1 (en) | 2023-02-28 | 2023-05-30 | 주식회사 위즈온컴퍼니 | Lip balm composition and manufacturing method thereof |
-
2023
- 2023-06-12 KR KR1020230074765A patent/KR102641072B1/en active IP Right Grant
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20200035485A (en) * | 2015-10-29 | 2020-04-03 | 글락소스미스클라인 컨슈머 헬스케어 홀딩스 (유에스) 엘엘씨 | Novel occlusive compositions |
| KR20200046060A (en) * | 2015-10-29 | 2020-05-06 | 글락소스미스클라인 컨슈머 헬스케어 홀딩스 (유에스) 엘엘씨 | Novel occlusive formulations |
| KR102518286B1 (en) | 2020-10-28 | 2023-04-05 | 코스맥스 주식회사 | Cosmetic composition for manufacturing stick typed lip balm and stick typed lip balm having an enhanced usability and functionality manufactured by the same |
| KR102461841B1 (en) | 2022-05-25 | 2022-11-02 | 주식회사 네츄럴샤인 | Lip balm composition for lip protection that provides double moisturizing |
| KR102535756B1 (en) | 2023-02-28 | 2023-05-30 | 주식회사 위즈온컴퍼니 | Lip balm composition and manufacturing method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102342993B (en) | Anti-sensitization and restoration external preparation for skin | |
| WO2008140200A1 (en) | External compositions for the skin | |
| CN105853260B (en) | A kind of diaper dermatitis frost and preparation method thereof | |
| KR101897488B1 (en) | Cosmetic composition for Strengthening skin barrier, skin regeneration and skin moisturization | |
| CN105055251A (en) | Anti-aging cosmetic and preparation method thereof | |
| KR102326796B1 (en) | Cosmetic materials composition for skin anti-oxidant and skin-soothing, Cosmetic materials using the same and Manufacturing method thereof | |
| CN108653013A (en) | A kind of plant moisturizing water profit after-sun frost and preparation method thereof | |
| CN107184448A (en) | A kind of acne eliminating cream that there is prevention pockmark to generate | |
| CN105816848A (en) | Protective cream capable of dispelling dampness and preparation method thereof | |
| KR101810229B1 (en) | Cosmetic composition for improving acne containing teatree leaves spicule powder | |
| CN108938501A (en) | Chinese medicine composition and oral care product applied to oral care product | |
| KR100750206B1 (en) | A medicines using photosynthetic bacteria for skin disease | |
| KR101142541B1 (en) | Anti-wrinkle cosmetic composition containing oriental herb extract treated by enzyme and its extraction method | |
| JP2006137690A (en) | Skin external preparation and hyaluronic acid production accelerator | |
| CN103494737A (en) | Cosmetic preparation using ginger flower as anti-ageing and skin-protecting factor and preparation method of cosmetic preparation | |
| KR102165525B1 (en) | Composition for improving acne skin | |
| JP2009269904A (en) | Herbal medicinal composition for curing external wound and bedsore and method of manufacturing medicine from the composition | |
| CN103800401B (en) | Granulation promoting healing ointment | |
| KR100905437B1 (en) | Composition for treating of atopic dermatitis and preparing method thereof | |
| KR102641072B1 (en) | Lip balm composition and lip balm prepared including the same | |
| KR102032293B1 (en) | Natural body washes using bamboo salt and manufacturing method thereof | |
| KR101893012B1 (en) | Method for Manufacturing Soap Containing Fermented Medicinal Herbs Include Ginseng | |
| KR100505486B1 (en) | Fiber with biological material and its manufacturing method | |
| KR102293585B1 (en) | Wax-type cleanser | |
| CN111939215A (en) | Composition for treating bromhidrosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| E701 | Decision to grant or registration of patent right | ||
| N231 | Notification of change of applicant | ||
| GRNT | Written decision to grant |